You are here

Michael Knopp

  • Professor, Radiology
  • Professor, Computer Science & Engineering
  • Professor, Radiation Oncology
  • Professor, SBS-Biomedical Informatics
  • Professor, Veterinary Clinical Sciences
  • Room #430
    395 W 12th Ave
    Columbus, OH 43210
  • 614-293-9998

Honors

  • 20161101

    Distinguished Investigator Award.

  • 20160601

    Second Place Poster - Educational Exhibits.

  • 20160501

    One of the Top 25 JMRI papers in the last 25 years.

  • 20160301

    Best Scientific Paper Presentation –Oncologic Imaging.

  • 20151201

    Outstanding Technology Team 2015 BizTech Awards.

  • 20150101

    2014 Radiology Editor’s Recognition Award for reviewing with Distinction.

  • 20120601

    Tech Oral Presentation Award: 1st Place: Quantitatively accurate dynamic SPECT/CT acquisition: Proof of concept in an antropomorphic phantom.

  • 20120201

    Innovation in Non-Profit Service Delivery.

  • 20120201

    Outstanding Technology Team - Runner Up.

  • 20111001

    Best Poster Award: Intravitreal Characteristics of I-124 Labelled Avastin and Lucentis with PET/CT.

  • 20101101

    Certificate of Merit, Education Exhibit: The Human Brain in 2010 Pieces: An Interactive 3D Atlas of Structure, Vasculature, Tractography, and Function.

  • 20100901

    Third Best Poster Award: Imaging of Retro-Orbital Vasculature and Central Retinal Vasculature with Ultra High Field 7T Magnetic Resonance Imaging Using Dedicated Eye Coil.

  • 20091101

    Magna Cum Laude Award, Education Exhibit: The Human Brain in 1,002 Pieces: A Comprehensive and Interactive 3D Atlas of Structure, Vasculature, and Connections from Multiple 3T and 7T Acquisitions.

  • 20091101

    Certificate of Merit, Education Exhibit: Influences of the Parallel Imaging Technique SENSE on Ultra High Field Diffusion Tensor Imaging and Fibertracking at 7T.

  • 20090501

    Magna Cum Laude Award: A 3D Interactive Atlas of Cerebral Vasculature and Structure from 3T and 7T.

  • 20081101

    Certificate of Merit, Education Exhibit: A 3D Interactive Atlas of Cerebral Arteries from 7T.

  • 20080401

    Certificate of Merit, Educational Electronic Exhibit Awards: Imaging-pathology Correlation of 3T DCE-MRI without an Endorectal Coil used as a Presurgical Roadmap for Prostate Cancer Delineation.

  • 20080101

    Kenneth R. Gottesfeld Award: Image segmentation for evaluating axillary lymph nodes.

  • 20070501

    Contrast Media Research Award: Schelle MR- Kontrastmitteldynamik zur Charakterisierung von Tuumoren: Erfahrungen mit der funktionellen MR- Mammographie.

  • 20070401

    Top 25 Innovators in Healthcare.

  • 20061201

    Doctor of Science, honoris causa.

  • 20040401

    John K. Lattimer Award.

  • 20011101

    Certificate of Merit, Scientific Exhibit Award: How to Implement an MRI Service for Functional Tumor Imaging?.

  • 20011101

    Magna Cum Laude Award, Scientific Exhibit: Monitoring of Breast Cancer Therapy with MRI: A Clinical Review of Indications, Findings, and Interpretation.

  • 20001101

    Certificate of Merit, Scientific Exhibit Award: Contrast Agents for MR Angiography: What Is or Will Be Available and Are There Differences?.

  • 20001101

    Certificate of Merit, Scientific Exhibit Award: Using Virtual Reality to Display MR Angiography: Tips, Tricks, and Useful Applications.

  • 20000901

    Magna Cum Laude Poster Award: Phase II Studies of Gd-BOPTA (Multihance) for MR Angiography.

  • 20000301

    Poster Award: Dynamic MRI for monitoring of microcirculation in pleural mesothelioma: Clinical and histopathological correlation during therapeutic interventions.

  • 19990901

    Poster Award: Multiphasic MR angiography of liver lesions with gadobenate dimeglumine (Gd-BOPTA).

  • 19990301

    Poster Award: Is there a diagnostic benefit of gadobenate dimeglumine (Gd-BOPTA) for MR angiography?.

  • 19981101

    Poster Award: Stellenwert der funktionellen Magnetresonanztomographie (MRT) für die Onkologische Diagnostik.

  • 19970301

    Poster Award: Dynamic gadolinium-enhanced MRI - a novel prognostic factor to predict lymphatic spread and tumor proliferation in cervical carcinoma.

  • 19970301

    EAR-ECR Fellowship Award: Which histiological and molecular biological factors influence the enhancements of Gadolinium contrast agents in tumors? In viva assessments of a pathophysiological Concept in breast tumors.

  • 19970301

    Poster Award: Statistical methods for the assessment of radiological procedures: A paradigmatic application in functional MR-mammography.

  • 19951101

    Poster Award: MR-mammographische Darstellung von Fibroadenomen. Eine radiologisch/histologische Korrelation.

  • 19950301

    Poster Award: Proton-decoupled 31-P MR spectroscopy in the follow-up of neoadjuvant chemotherapy of breast cancer.

  • 19940401

    Poster Award (1st Place): FDG-PET zum Therapiemonitoring von kleinzelligen Bronchialkarzinomen.

  • 19930501

    Poster of the Day: Magnetic Resonance Urography - An alternative technique to x-ray urography.

  • 19921001

    Poster Award: Neue Einsatzmöglichkeiten der Farbdopplersonographie: Das Mediastinum und seine Erkrankungen.

  • 19920501

    Poster Award: Fehlende Repopulation des Knochenmarks nach Strahlentherapie bei M. Hodgkin: MR-Tomographie und Quantifizierung durch "Chemical Shift Imaging.

Books

2010

  • Nowinski WL, Chua BC, Qian G, Marchenko Y, Puspitasari F, Nowinska NG, Knopp MV. 2010. "The Human Brain in 1492 Pieces: Structure, Vasculature, and Tracts." Thieme.

1996

  • 1996. "Cranial nerve imaging for radiosurgery at the base of the skull." S. Karger AGS. Karger AG.

1994

  • 1994. "Computer-assisted image analysis: A new diagnostic aid for quantitation of color Doppler information in breast tumors." S. Karger AGS. Karger AG.

Chapters

2016

  • 2016. "X ray, MRI and Ultrasound Agents: Basic Principles." In Handbook of Small Animal Imaging: Preclinical Imaging, Therapy, and Applications, edited by Kagadis GC, Ford NL, Loudos GK, Karnabatidis D,

2011

  • 2011. "Quality Assurance of Clinical Trials in the Management of Cancer in the Head and Neck." In Head and Neck Cancer: Multimodality Management, edited by Jacques Bernier,

2005

  • 2005. "Dynamic Contrast-Enhanced MRI in Carcinoma of the Breast." In Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Oncology, edited by Jackson A, Buckley DL, Parker GJM,

Journal Articles

2016

  • Villalona-Calero MA, Lam E, Otterson GA, Zhao W, Timmons M, Subramaniam D, Hade EM, Gill GM, Coffey M, Selvaggi G, Bertino E, Chao B, Knopp MV, 2016, "Oncolytic reovirus in combination with chemotherapy in metastatic or recurrent non-small cell lung cancer patients with KRAS-activated tumors." Cancer 122, no. 6, 875-83 - 875-83.
  • A Magnussen, R.; Binzel, K.; Zhang, J.; Wei, W. et al., 2016, "ACL graft metabolic activity assessed by 18FDG PET-MRI." Knee
  • FitzGerald, T.J.; Bishop-Jodoin, M.; Followill, D.S.; Galvin, J. et al., 2016, "Imaging and Data Acquisition in Clinical Trials for Radiation Therapy." International Journal of Radiation Oncology*Biology*Physics 94, no. 2, 404-411 - 404-411.
  • Rezai, A.R.; Sederberg, P.B.; Bogner, J.; Nielson, D.M. et al., 2016, "Improved Function After Deep Brain Stimulation for Chronic, Severe Traumatic Brain Injury." NEUROSURGERY 79, no. 2, 204-210 - 204-210.
  • Borniger, J.C.; Ding, H.; Williams, M.; Tweedle, M.F. et al., 2016, "Photoperiod affects organ specific glucose metabolism in male Siberian hamsters (Phodopus sungorus).." Journal of Clinical and Molecular Endocrinology 1, 1-8 - 1-8.

2015

  • Ammirati M, Lamki T, Chitnis G, Yang X, Russell D, Coble D, Kaur B, Knopp MV, Moore S, Ziaie B, 2015, "In vivo brain electrophoresis – a novel method for chemotherapy of CNS diseases." Expert Opin Drug Deliv 12, no. 5, 727-34 - 727-34.
  • Wright CL, Zhang J, Tweedle MF, Knopp MV, Hall NC, 2015, "Theranostic Imaging of Yttrium-90." Biomed Res Int 2015, 481279 - 481279.
  • Ammirati, M.; Lamki, T.; Chitnis, G.; Yang, X. et al., 2015, "In vivo brain electrophoresis - a novel method for chemotherapy of CNS diseases.." Expert opinion on drug delivery 12, no. 5, 727-734 - 727-734.
  • Nguyen HT, Jia G, Shah ZK, Pohar K, Mortazavi A, Zynger DL, Wei L, Yang X, Clark D, Knopp MV, 2015, "Prediction of chemotherapeutic response in bladder cancer using K-means clustering of dynamic contrast-enhanced (DCE)-MRI pharmacokinetic parameters." J Magn Reson Imaging 41, no. 5, 1374-82 - 1374-82.
  • Shah ZK, Elias SN, Abaza R, Zynger DL, DeRenne LA, Knopp MV, Guo B, Schurr R, Heymsfield SB, Jia G, 2015, "Performance Comparison of 1.5-T Endorectal Coil MRI with 3.0-T Nonendorectal Coil MRI in Patients with Prostate Cancer." Acad Radiol 22, no. 4, 467-74 - 467-74.

2014

  • Mrózek E, Layman R, Ramaswamy B, Lustberg M, Vecchione A, Knopp MV, Shapiro CL, 2014, "Phase II Trial of Neoadjuvant Weekly Nanoparticle Albumin-Bound Paclitaxel, Carboplatin, and Biweekly Bevacizumab Therapy in Women With Clinical Stage II or III HER2-Negative Breast Cancer." Clin Breast Cancer 14, no. 4, 228-34 - 228-34.
  • Mrozek E, Layman R, Ramaswamy B, Lustberg M, VcchioneA, Knopp MV, Shapiro CL, 2014, "Phase II Trial of Neoadjuvant Weekly Nanoparticle Albumin-Bound Paclitaxel, Carboplatin, and Biweekly Bevacizumab Therapy in Women With Clinical Stage II or III HER2-Negative Breast Cancer." Clin Breast Cancer 14, no. 4, 228-34 - 228-34.
  • Huang Z, Yuh KA, Lo SS, Grecula JC, Sammet S, Sammet CL, Jia G, Knopp MV, Wu Q, Beauchamp NJ 3rd, Yuh WT, Wang R, Mayr NA, 2014, "Improving Bladder Cancer Imaging Using 3-T Functional Dynamic Contrast-Enhanced Magnetic Resonance Imaging." J Magn Reson Imaging 32, no. 10, 1198-205 - 1198-205.
  • Nguyen HT, Pohar KS, Jia G, Shah ZK, Mortazavi A, Zynger DL, Wei L, Clark D, Yang X, Knopp MV, 2014, "Improving Bladder Cancer Imaging Using 3-T Functional Dynamic Contrast-Enhanced Magnetic Resonance Imaging." Invest Radiol 49, no. 6, 390-5 - 390-5.

2013

  • Campbell AB, Knopp MV, Kolovich G, Wei W, Jia G, Siston RA, Flanigan DC, 2013, "Preoperative MRI Underestimates Articular Cartilage Defect Size Compared to Arthroscopy." Am J Sports Med 41, no. 3, 590-5 - 590-5.
  • Povoski SP, Hall NC, Murrey DA Jr, Chow AZ, Gaglani JR, Bahnson EE, Mojzisik CM, Kuhrt MP, Hitchcock CL, Knopp MV, Martin EW Jr, 2013, "Multimodal Imaging and Detection Strategy with 124 I-Labeled Chimeric Monoclonoal Antibody cG250 for Accurate Localization and Confirmation of Extent of Disease During Laparoscopic and Open Surgical Resection of Clear Cell Renal Cell Carcinoma." Surg Innov 20, no. 1, 59-69 - 59-69.
  • FitzGerald, T.J.; Bishop-Jodoin, M.; Bosch, W.R.; Curran, W.J. et al., 2013, "Future vision for the quality assurance of oncology clinical trials." Frontiers in Oncology 3,
  • Sammet, C.L.; Yang, X.; Wassenaar, P.A.; Bourekas, E.C. et al., 2013, "RF-related heating assessment of extracranial neurosurgical implants at 7 T." MAGNETIC RESONANCE IMAGING 31, no. 6, 1029-1034 - 1029-1034.
  • Christoforidis, J.B.; Williams, M.M.; Wang, J.; Jiang, A. et al., 2013, "Anatomic and pharmacokinetic properties of intravitreal bevacizumab and ranibizumab after vitrectomy and lensectomy.." Retina (Philadelphia, Pa.) 33, no. 5, 946-952 - 946-952.
  • Stamm AC, Wright CL, Knopp MV, Schmalbrock P, Heverhagen JT, 2013, "Phase contrast and time-of-flight magnetic resonance angiography of the intracerebral arteries at 1.5, 3 and 7T." Magn Reson Imaging 31, no. 4, 545-9 - 545-9.
  • Nowinski WL, Puspitasaari F, Volkau I, Marchenko Y, Knopp MV, 2013, "Comparison of Magnetic Resonance Angiography Scans on 1.5, 3, and 7 Tesla Units: A Quantitative Study of Three-Dimensional Cerebrovasculature." J Neuroimaging 23, no. 1, 86-95 - 86-95.

2012

  • Mayr, N.A.; Huang, Z.; Wang, J.Z.; Lo, S.S. et al., 2012, "Characterizing Tumor Heterogeneity With Functional Imaging and Quantifying High-Risk Tumor Volume for Early Prediction of Treatment Outcome: Cervical Cancer as a Model." INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 83, no. 3, 972-979 - 972-979.
  • Martin LK, Jia G, Wei L, Yang X, Grecula J, Otterson G, Harper E, Kefauver C, Shah ZK, Zhou B, Yen Y, Bloomston M, Knopp MV, Espinoza-Delgado I, Grever M, Bekaii-Saab T, 2012, "A dose escalation and pharmacodynamic study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine) and radiation in patients with locally advanced pancreas cancer." Int J Radiat Oncol 84, no. 4, e475-81 - e475-81.
  • Yang X, Mrozek E, Lustberg M, Jia G, Sammet S, Sammet C, Shapiro C, Knopp MV, 2012, "Microcirculatory Fraction (MCFi) as a Potential Imaging Marker for Tumor." Magn Reson Imaging 30, no. 8, 1059-67 - 1059-67.
  • Mayr NA, Huang Z, Wang JZ, Lo SS, Fan JM, Grecula JC, Sammet S, Sammet CL, Jia G, Zhang J, Knopp MV, Yuh WT, 2012, "Characterizing Tumor Heterogeneity with Functional Imaging and Quantifying High-Risk Tumor Volume for Early Prediction of Treatment Outcome: Cervical Cancer as a Model." Int J Radiat Oncol Biol Phys 83, no. 3, 972-9 - 972-9.
  • Harris JD, Brophy RH, Jia G, Price B, Knopp MV, Siston RA, Flanigan DC, 2012, "Sensitivity of Magnetic Resonance Imaging for Detection of Patellofemoral Articular Cartilage Defects." Arthroscopy 28, no. 11, 1728-37 - 1728-37.
  • Mayr NA, Huang Z, Wang JZ, Lo SS, Fan JM, Grecula JC, Sammet S, Sammet CL, Jia G, Zhang J, Knopp MV, Yuh WT, 2012, "Characterizing Tumor Heterogeneity with Functional Imaging and Quantifying High-Risk Tumor Volume for Early Prediction of Treatment Outcome: Cervical Cancer as a Model." Int J Radiat Oncol Biol Phys

2011

  • Jia G, Takayama Y, Flanigan DC, Kaeding CC, Zhou J, Chaudhari A, Clark D, Sammet S, Liang J, Choi S, Knopp MV, 2011, "Quantitative Assessment of Mobile Protein Levels in Human Knee Synovial Fluid: Feasibility of Chemical Exchange Saturation Transfer (proteinCEST) MRI of Osteoarthritis." Magn Reson Imaging 29, no. 3, 335-41 - 335-41.
  • Jia G, Abaza R, Williams JD, Zynger DL, Zhou J, Shah ZK, Patel M, Sammet S, Wei L, Bahnson RR, Knopp MV, 2011, "Amide Proton Transfer MR Imaging of Prostate Cancer: A Preliminary Study." J Magn Reson Imaging 33, no. 3, 647-54 - 647-54.
  • Bluestein KT, Pitt D, Knopp MV, Schmalbrock P, 2011, "T1 and Proton Density at 7T in Patients with Multiple Sclerosis: An Initial Study." Magn Reson Imaging
  • Menendez MI, Clark DJ, Carlton M, Flanigan DC, Jia G, Sammet S, Weisbrode SE, Knopp MV, Bertone AL, 2011, "Direct delayed human adenoviral BMP-2 or BMP-6 gene therapy for bone and cartilage regeneration in a pony osteochondral model." Osteoarthritis Cartilage 19, no. 8, 1066-75 - 1066-75.
  • Christoforidis GA, Rink C, Kontzialis MS, Mohammad Y, Koch RM, Abduljalil AM, Bergdall VK, Roy S, Khanna S, Slivka AP, Knopp MV, Sen CK, 2011, "An Endovascular Canine Middle Cerebral Artery Occlusion Model for the Study of Leptomeningeal Collateral Recruitment." Invest Radiol 46, no. 1, 34-40 - 34-40.
  • Choi S, Cunningham DT, Aguila F, Corrigan JD, Bogner J, Mysiw WJ, Knopp MV, Schmalbrock P, 2011, "DTI at 7T and 3T: Systematic Comparison of SNR and its Influence on Quantitative Metrics." Magn Reson Imaging 29, no. 6, 739-51 - 739-51.
  • Povoski SP, Hall NC, Murrey DA Jr, Chow AZ, Gaglani JR, Bahnson EE, Mojzisik CM, Kuhrt MP, Hitchcock CL, Knopp MV, Martin EW Jr, 2011, "Multimodal imaging and detection approach to 18F-FDG-directed surgery for patients with known or suspected malignancies: a comprehensive description of the specific methodology utilized in a single-institution cumulative retrospective experience." World J Surg Oncol 9, 152 - 152.
  • Christoforidis, J.B.; Carlton, M.M.; Knopp, M.V.; Hinkle, G.H., 2011, "PET/CT imaging of I-124-radiolabeled bevacizumab and ranibizumab after intravitreal injection in a rabbit model.." Investigative ophthalmology & visual science 52, no. 8, 5899-5903 - 5899-5903.
  • Yuh WTC, Christoforidis GA, Mayr NA, Sammet CT, Nowinski WL, Knopp MV, Sammet S, 2011, "Ultrahigh field clinical MR imaging: Challenge and excitement." US Radiology 3, no. 1, 16-22 - 16-22.
  • Poon, D.P.; Langkals, J.W.; Giesel, F.L.; Knopp, M.V. et al., 2011, "Internet-Based Videoconferencing and Data Collaboration for the Imaging Community." JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY 35, no. 6, 753-761 - 753-761.

2010

  • Liang, J.; Sammet, S.; Yang, X.; Jia, G. et al., 2010, "Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.." Investigative radiology 45, no. 5, 233-244 - 233-244.
  • Lam ET, Ringel MD, Kloos KT, Prior T, Knopp MV, Liang J, Sammet S, Hall NC, Wakely Jr PE, Vasko VV, Saji M, Snyder P, Wei L, Arbogast D, Collamore M, Wright JJ, Moley J, Villalona-Calero MA, Shah MH, 2010, "Phase II Clinical Trial of the Multi-Kinase Inhibitor, Sorafenib, in Metastatic Medullary Thyroid Cancer." J Clin Oncol 28, no. 14, 2323-30 - 2323-30.
  • Steinberg J, Jia G, Sammet S, Zhang J, Hall NC, Knopp MV, 2010, "Three-region MRI-based whole-body attenuation correction for automated PET reconstruction." Nucl Med Biol 37, no. 2, 227-35 - 227-35.
  • Zou P, Povoski SP, Hall NC, Carlton MM, Hinkle GH, Xu RX, Mojzisik CM, Johnson MA, Knopp MV, Martin EW Jr, Sun D, 2010, "124I-HuCC49deltaCH2 for TAG-72 antigen-directed positron emission tomography (PET) imaging of LS174T colon adenocarcinoma tumor implants in xenograft mice: preliminary results." World J Surg Onc 8, 65 - 65.
  • Hall NC, Povoski SP, Murrey DA, Martin EW Jr, Knopp MV, 2010, "Ex vivo specimen FDG PET/CT imaging for oncology." Radiology 255, no. 2, 663-4; author reply - 663-4; author reply.
  • Mayr NA, Wang JZ, Zhang D, Grecula JC, Lo SS, Jaroura D, Montebello J, Zhang H, Li K, Lu L, Huang Z, Fowler JM, Wu DH, Knopp MV, Yuh WT, 2010, "Longitudinal Changes in Tumor Perfusion Pattern during the Radiation Therapy Course and its Clinical Impact in Cervical Cancer." Int J Radiat Oncol Biol Phys 77, no. 2, 502-8 - 502-8.
  • Yang, X.; Sammet, S.; Schmalbrock, P.; Knopp, M.V., 2010, "Postprocessing correction for distortions in T2* decay caused by quadratic cross-slice B0 inhomogeneity.." Magnetic resonance in medicine 63, no. 5, 1258-1268 - 1258-1268.
  • Lam, E.T.; Ringel, M.D.; Kloos, R.T.; Prior, T.W. et al., 2010, "Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer.." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 28, no. 14, 2323-2330 - 2323-2330.

2009

  • Heverhagen JT, Wright CL, Schmalbrock P, Knopp MV, 2009, "Dose comparison of single versus double dose in contrast-enhanced magnetic resonance angiography of the renal arteries: intra-individual cross-over blinded trial using Gd-DTPA." Eur Radiol 19, no. 1, 67-72 - 67-72.
  • Kloos RT, Ringel MD, Knopp MV, Hall NC, King M, Stevens R, Liang J, Wakely PE Jr, Vasko VV, Saji M, Rittenberry J, Wei L, Arbogast D, Collamore M, Wright JJ, Grever M, Shah MH, 2009, "Phase II Trial of Sorafenib in Metastatic Thyroid Cancer." J Clin Oncol 27, no. 10, 1675-84 - 1675-84.
  • Hall NC, Zhang J, Povoski SP, Martin EW Jr, Knopp MV, 2009, "New developments in imaging and functional biomarker technology for the assessment and management of cancer patients." Expert Rev Med Devices 6, no. 4, 347-51 - 347-51.
  • Murrey DA Jr, Bahnson EE, Hall NC, Povoski SP, Mojzisik CM, Young DC, Sharif S, Johnson MA, Abdel-Misih S, Martin EW Jr, Knopp MV, 2009, "Perioperative (18)F-fluorodeoxyglucose-guided using the becquerel as a quantitative measure for optimizing surgical resection in patients with advanced malignancy." Am J Surg 198, no. 6, 834-40 - 834-40.
  • Nijdam AJ, Nicholson III TR, Shapiro JP, Smith BR, Heverhagen JT, Schmalbrock P, Knopp MV, Kebbel A, Wang D, Lee SC, 2009, "Nanoparticulate Iron Oxide Contrast Agents for Untargeted and Targeted Cardiovascular Magnetic Resonance Imaging." Curr Nanosci 5, no. 1, 88-102 - 88-102.
  • Povoski SP, Neff RL, Mojzisik CM, O'Malley DM, Hinkle GH, Hall NC, Murrey DA Jr, Knopp MV, Martin EW Jr, 2009, "A Comprehensive Overview of Radioguided Surgery Using Gamma Detection Probe Technology." World J Surg Oncol 7, no. 1, 11. Review - 11. Review.
  • Yuh WT, Mayr NA, Jarjoura D, Wu D, Grecula JC, Lo SS, Edwards SM, Magnotta VA, Sammet S, Zhang H, Montebello JF, Fowler J, Knopp MV, Wang JZ, 2009, "Predicting Control of Primary Tumor and Survival by DCE MRI During Early Therapy in Cervical Cancer." Invest Radiol 44, no. 6, 343-50 - 343-50.
  • Christoforidis, G.A.; Yang, M.; Kontzialis, M.S.; Larson, D.G. et al., 2009, "High resolution ultra high field magnetic resonance imaging of glioma microvascularity and hypoxia using ultra-small particles of iron oxide.." Investigative radiology 44, no. 7, 375-383 - 375-383.
  • Bahnson EE, Murrey DA, Mojzisik CM, Hall NC, Martinez-Suarez HJ, Knopp MV, Martin EW, Povoski SP, Bahnson RR, 2009, "PET/CT imaging of clear cell renal cell carcinoma with I labeled chimeric antibody.." Ther Adv Urol 1, no. 2, 67-70 - 67-70.
  • Christoforidis GA, Yang M, Kontzialis MS, Larson DG, Abduljalil A, Basso M, Yang W, Ray-Chaudhury A, Heverhagen JT, Knopp MV, Barth RF, 2009, "High resolution ultra-high field magentic resonance imaging of glioma microvascularity and hypoxia using ultra-small particles of iron oxide." Invest Radiol 44, no. 7, 375-83 - 375-83.

2008

  • Heverhagen, J.T.; Bourekas, E.; Sammet, S.; Knopp, M.V. et al., 2008, "Time-of-flight magnetic resonance angiography at 7 tesla." INVESTIGATIVE RADIOLOGY 43, no. 8, 568-573 - 568-573.
  • Hall NC, Povoski SP, Murrey DA, Knopp MV, Martin EW, 2008, "Bringing Advanced Medical Imaging into the Operative Arena Could Revolutionize the Surgical Care of Cancer Patients." Expert Review of Medical Devices 5, no. 6, 663-7 - 663-7.
  • Cao X, Bloomston M, Zhang T, Frankel WL, Jia G, Wang B, Hall NC, Koch RM, Cheng H, Knopp MV, Sun D, 2008, "Synergistic Antipancreatic Tumor Effect by Simultaneously Targeting Hypoxic Cancer Cells With HSP90 Inhibitor and Glycolysis Inhibitor." Clin Cancer Res 14, no. 6, 1831-9 - 1831-9.
  • Rink C, Christoforidis G, Abduljalil A, Kontzialis M, Bergdall V, Roy S, Khanna S, Slivka A, Knopp MV, Sen CK, 2008, "Minimally invasive neuroradiologic model of preclinical transient middle cerebral artery occlusion in canines." Proc Natl Acad Sci USA 105, no. 37, 14100-5 - 14100-5.
  • Povoski SP, Sarikaya I, White WC, Marsh SG, Hall NC, Hinkle GH, Martin EW Jr, Knopp MV, 2008, "Comprehensive Evaluation of Occupational Radiation Exposure to Intraoperative and Perioperative Personnel from 18F-FDG Radioguided Surgical Procedures." Eur J Nucl Med Mol Imaging 35, no. 11, 2026-34 - 2026-34.

2007

  • Sarikaya I, Bloomston M, Povoski SP, Zhang J, Hall NC, Knopp MV, Martin EW Jr, 2007, "FDG-PET Scan in Patients with Clinically and/or Radiologically Suspicious Colorectal Cancer Recurrence but Normal CEA." World J Surg Oncol 5, 64 - 64.
  • Smith BR, Heverhagen J, Knopp M, Schmalbrock P, Shapiro J, Shiomi M, Moldovan NI, Ferrari M, Lee SC, 2007, "Localization to atherosclerotic plaque and biodistribution of biochemically derivatized superparamagnetic iron oxide nanoparticles (SPIONs) contrast particles for magnetic resonance imaging (MRI).." Biomed Microdevices 9, no. 5, 719-27 - 719-27.
  • Sarikaya I, Povoski SP, Al-Saif OH, Kocak E, Bloomston M, Marsh S, Cao Z, Murrey DA, Zhang J, Hall NC, Knopp MV, Martin EW Jr, 2007, "Combined use of preoperative 18F FDG-PET imaging and intraoperative gamma probe detection for accurate assessment of tumor recurrence in patients with colorectal cancer." World J Surg Oncol 5, 80 - 80.
  • Woods BJ, Clymer BD, Heverhagen JT, Knopp MV, Saltz J, Kurc T, 2007, "Parallel four-dimensional Haralick texture analysis for disk-resident image datasets." Concurrency Computat Pract Exper 19, no. 1, 65-87 - 65-87.
  • Hall NC, Povoski SP, Murrey DA, Knopp MV, Martin EW Jr, 2007, "Combined approach of perioperative 18F-FDG PET/CT imaging and intraoperative 18F-FDG handheld gamma probe detection for tumor localization and verification of complete tumor resection in breast cancer." World J Surg Oncol 5, 143 - 143.

2006

  • Jia G, Heverhagen JT, Polzer H, Jacko RV, Liang J, Zhang J, Levine AL, Rosol TJ, Knopp MV, 2006, "Dynamic contrast enhanced magnetic resonance imaging as a biological marker to noninvasively assess the effect of finasteride on prostatic suburethral microcirculation." J Urol 176, no. 5, 2299-304 - 2299-304.
  • Knopp, M.V.; Balzer, T.; Esser, M., 2006, "Erratum: Assessment of utilization and pharmacovigilance based on spontaneous adverse event reporting of gadopentetate dimeglumine as a magnetic resonance contrast agent after 45 million administrations and 15 years of clinical use (Investigative Radiology (2006) 41 (491-499))." Investigative Radiology 41, no. 9, 667 - 667.
  • Yuh, W.T.C.; Christoforidis, G.A.; Koch, R.M.; Sammet, S. et al., 2006, "Clinical magnetic resonance imaging of brain tumors at ultrahigh field: a state-of-the-art review.." Topics in magnetic resonance imaging : TMRI 17, no. 2, 53-61 - 53-61.

2005

  • Jia G, Baudendistel KT, von Tengg-Kobligk H, Heverhagen JT, Polzer H, Henry H, McAuliffe MJ, Levine AL, Rosol TJ, Knopp MV, 2005, "Assessing prostate volume by magnetic resonance imaging: a comparison of different measurement approaches for organ volume analysis." Invest Radiol 40, no. 4, 243-8 - 243-8.

2004

  • Heverhagen JT, von Tengg-Kobligk H, Baudendistel KT, Jia G, Polzer H, Henry H, Levine AL, Rosol TJ, Knopp MV, 2004, "Benign prostate hyperplasia: evaluation of treatment response with DCE MRI." MAGMA 17, no. 1, 5-11 - 5-11.
  • Prince MR, Choyke PL, Knopp MV, 2004, "More on pseudohypocalcemia and gadolinium-enhanced MRI." N Engl J Med 350, no. 1, 87-8; author reply 87 - 87-8; author reply 87.

2003

  • Kroencke, T.J.; Wasser, M.N.; Pattynama, P.M.T.; Barentz, J.O. et al., 2003, "Gadobenate dimeglumine-enhanced MR angiography of the abdominal aorta and renal arteries." Applied Radiology 32, no. 4 SUPPL., 221-233 - 221-233.
  • Wasser, K.; Klein, S.K.; Fink, C.; Junkermann, H. et al., 2003, "Evaluation of neoadjuvant chemotherapeutic response of breast cancer using dynamic MRI with high temporal resolution." EUROPEAN RADIOLOGY 13, no. 1, 80-87 - 80-87.
  • Helbig M, Schlemmer HP, Lumer M, Knopp MV, Dietz A, 2003, "[Dynamic magnetic resonance tomography (dMRT). It's value in advanced head-neck tumors treated with radiochemotherapy]." HNO 51, no. 11, 886-92 - 886-92.
  • Knopp, M.V.; Schoenberg, S.O.; Rehm, C.; Floemer, F. et al., 2003, "Assessment of gadobenate dimeglumine for magnetic resonance angiography phase I studies." Applied Radiology 32, no. 4 SUPPL., 211-220 - 211-220.
  • Essig, M.; Hartmann, M.; Lodermann, K.P.; Jansen, O. et al., 2003, "Comparison of Gd-BOPTA and Gd-DTPA for contrast-enhanced MRI of intra-axial cerebral tumors: A two-center, double-blind, randomized, intra-individual crossover study." Applied Radiology 32, no. 4 SUPPL., 92-100 - 92-100.
  • Maki, J.H.; Knopp, M.V.; Prince, M., 2003, "Contrast-enhanced MR angiography." Applied Radiology 32, no. 4 SUPPL., 182-210 - 182-210.

2002

  • Knopp MV, Himmelhan N, Radeleff J, Junkermann H, Hess T, Sinn HP, Brix G, 2002, "[Comparison of methods for quantifying contrast enhancement exemplified by dynamic MRI mammography]." Radiologe 42, no. 4, 280-90 - 280-90.

2001

  • Essig M, Hartmann M, Lodemann KP, Jansen O, Seeberg A, Runge VM, Knopp MV, 2001, "[Comparison of contrast behavior of gadobenate-dimeglumine and Gd-DTPA in intra-axial brain tumors. A double-blind randomized intraindividual cross-over study]." Radiologe 41, no. 12, 1063-71 - 1063-71.
  • Knopp MV, Lodemann M, Kage U, Runge VM, 2001, "[Administration of MR contrast agents outside of approved indications (off-label use]." Radiologe 41, no. 3, 296-302 - 296-302.

2000

  • Schoenberg SO, Bock M, Aumann S, Just A, Essig M, Floemer F, Knopp MV, van Kaick G, 2000, "[Quantitative recording of renal function with magnetic resonance tomography]." Radiologe 40, no. 10, 925-37. Review - 925-37. Review.
  • Brix, G.; Griebel, J.; Knopp, M.V.; Bernhardt, J.H., 2000, "Safety aspects in the application of magnetic resonance techniques in medical diagnostics." Zeitschrift fur Medizinische Physik 10, no. 1, 5-14 - 5-14.
  • Floemer F, Glombitza G, Knopp MV, Schoenberg SO, Brockmeier K, Meinzer HP, 2000, "[Use of virtual reality for MRI data of complex vascular structures]." Radiologe 40, no. 3, 246-55 - 246-55.
  • Essig M, Deimling M, Schoenberg SO, Debus J, Knopp MV, van Kaick G, 2000, "[HIRE (high intensity reduction). New cerebrospinal fluid suppressed T2-weighted imaging sequence]." Radiologe 40, no. 12, 1163-71 - 1163-71.

1999

  • Metzner, R.; Bonsanto, M.M.; Essig, M.; Staubert, A. et al., 1999, "Presurgical fMRI: Fast, exact and affordable evaluation, standardized examination." NeuroImage 9, no. 6 PART II,
  • Schoenberg SO, Knopp MV, Bock M, Floemer F, Kallinowski F, Essig M, Hawighorst H, Just A, Laub G, Prince MR, van Kaick G, 1999, "[MRI of the kidneys. New diagnostic strategies]." Radiologe 39, no. 5, 373-85 - 373-85.
  • Pantel, J.; Schröder, J.; Jauss, M.; Essig, M. et al., 1999, "Topography of callosal atrophy reflects distribution of regional cerebral volume reduction in Alzheimer's disease - A study using quantitative magnetic resonance imaging." NeuroImage 9, no. 6 PART II,
  • Scholdei R, Wenz F, Essig M, Fuss M, Knopp MV, 1999, "[The simultaneous determination of the arterial input function for dynamic susceptibility-weighted magnetic resonance tomography of the A. carotis interna and the A. cerebri media]." Rofo 171, no. 1, 38-43 - 38-43.
  • Essig M, Knopp MV, Debus J, Schönberg SO, Wenz F, Hawighorst H, van Kaick G, 1999, "[Fluid-attenuated-inversion-recovery (FLAIR) imaging in the diagnosis of cerebral gliomas and metastases]." Radiologe 39, no. 2, 151-60. Review - 151-60. Review.
  • Taylor, J.S.; Tofts, P.S.; Port, R.; Evelhoch, J.L. et al., 1999, "MR imaging of tumor microcirculation: Promise for the new millenium." Journal of Magnetic Resonance Imaging 10, no. 6, 903-907 - 903-907.
  • Metzner, R.; Meyer, H.; Baudendistel, K.; Essig, M. et al., 1999, "FMRI: Different degrees of cortical activation under monitored motoric stimulation." NeuroImage 9, no. 6 PART II,

1998

  • Hawighorst H, Bock M, Knopp MV, Essig M, Schoenberg SO, Knapstein PG, Schad LR, van Kaick G, 1998, "[MRI imaging of the uterine arterial blood flow in normal and malignant uterine tissue by means of 2d-multiphase tagging technic]." Radiologe 38, no. 6, 539-44 - 539-44.
  • Hawighorst H, Dörsam J, Knopp MV, Jugowski W, Schoenberg SO, Wiesel M, Essig M, van Kaick G, 1998, "[MR tomographic monitoring of prostate carcinoma after cryotherapy: initial results]." Rofo 168, no. 1, 44-8 - 44-8.
  • Knopp, M.V.; Floemer, F.; Zuna, I.; Van Kaick, G., 1998, "Erratum: Studiendesign in der klinisch-radiologischen Forschung (Der Radiologie (1998) 38 (241-247))." Radiologe 38, no. 7, 632 - 632.
  • Knopp MV, Obier C, Zuna I, Junkermann H, Hess T, Junkermann I, Brix G, van Kaick G, 1998, "[Multiple reader analysis for evaluation of functional MR mammography]." Radiologe 38, no. 4, 307-14 - 307-14.
  • Pantel J, Schröder J, Essig M, Schad LR, Popp D, Eysenbach K, Jauss M, Knopp MV, 1998, "[Volumetric brain findings in late depression. A study with quantified magnetic resonance tomography]." Nervenarzt 69, no. 11, 968-74 - 968-74.
  • Knopp MV, Floemer F, Zuna I, van Kaick G, 1998, "[Study design in clinical radiologic research]." Radiologe 38, no. 4, 241-7 - 241-7.

1997

  • Schröder J, Pantel J, Ida N, Essig M, Hartmann T, Knopp MV, Schad LR, Sandbrink R, Sauer H, Masters CL, Beyreuther K, 1997, "Cerebral changes and cerebrospinal fluid beta-amyloid in Alzheimer's disease: a study with quantitative magnetic resonance imaging." Mol Psychiatry 2, no. 6, 505-7 - 505-7.
  • Schoenberg SO, Just A, Bock M, Knopp MV, Persson PB, Kirchheim HR, 1997, "Noninvasive analysis of renal artery blood flow dynamics with MR cine phase-contrast flow measurements." Am J Physiol 272, no. 5 Pt 2, H2477-84 - H2477-84.
  • Schoenberg SO, Knopp MV, Bock M, Kallinowski F, Just A, Essig M, Hawighorst H, Zuna I, Schad L, Allenberg JR, van Kaick G, 1997, "[Classification of hemodynamic changes in renal artery stenosis using cine magnetic resonance phase contrast flow measurements]." Radiologe 37, no. 8, 651-62 - 651-62.
  • Knopp MV, Dörsam J, Oesingmann N, Piesche S, Hawighorst H, Wiesel M, Schad LR, van Kaick G, 1997, "[Functional MR urography in patients with kidney transplantation]." Radiologe 37, no. 3, 233-8 - 233-8.
  • Gerdsen, I.; Schröder, J.; Frost, S.; Baudendistel, K. et al., 1997, "Cerebral activation and motor task performance during externally triggered and self-initiated movement." NeuroImage 5, no. 4 PART II,
  • Pantel, J.; Schröder, J.; Essig, M.; Schad, L.R. et al., 1997, "Quantification of brain atrophy in subcortical vascular dementia and Alzheimer's disease - A MRI-based volumetric study." NeuroImage 5, no. 4 PART II,
  • Brix G, Schreiber W, Hoffmann U, Gückel F, Hawighorst H, Knopp MV, 1997, "[Methodological approaches to quantitative evaluation of microcirculation in tissues with dynamic magnetic resonance tomography]." Radiologe 37, no. 6, 470-80 - 470-80.
  • Hawighorst H, Knopp MV, Debus J, Brix G, Engenhart-Cabillic R, Schad LR, Grandy M, Essig M, van Kaick G, 1997, "[Morphologic MR imaging with T1-weighted sequences for radiotherapy goal volume definition of intracranial tumors. Comparison with FLASH-Turbo-FLASH and SE sequences]." Radiologe 37, no. 3, 243-50 - 243-50.
  • Hawighorst H, Knapstein PG, Weikel W, Knopp MV, Schaeffer U, Essig M, Brix G, Zuna I, Schönberg S, van Kaick G, 1997, "[Invasive cervix carcinoma (pT2b-pT4a). Value of conventional and pharmacokinetic magnetic resonance tomography (MRI) in comparison with extensive cross sections and histopathologic findings]." Radiologe 37, no. 2, 130-8 - 130-8.
  • Schröder, J.; Pantel, J.; Ida, N.; Essig, M. et al., 1997, "Cerebral Atrophy and cerebrospinal fluid ß-amyloid in dementia of the Alzheimer's type: A study with quantitative magnetic resonance imaging." NeuroImage 5, no. 4 PART II,
  • Baudendistel, K.; Schröder, J.; Essig, M.; Gerdssen, I. et al., 1997, "Sensorimotor cortex and supplementary motor area activation changes in schizophrenia: Studies with functional magnetic resonance imaging." NeuroImage 5, no. 4 PART II,
  • Essig, M.; Pantel, J.; Wenz, F.; Knopp, M.V. et al., 1997, "Cerebral blood volume in patients with dementia syndrome." NeuroImage 5, no. 4 PART II,

1996

  • Pantel J, Schröder J, Schmitt R, Schad LR, Knopp MV, Geissler M, Uhde WH, Blüml S, Friedlinger M, Klemenz M, Essig M, Sauer H, 1996, "[Quantitative magnetic resonance tomography and the severity of deficits in dementia of the Alzheimer type]." Nervenarzt 67, no. 1, 46-52 - 46-52.
  • Wenz F, Fuss M, Scholdei R, Essig M, Lohr F, Rempp K, Brix G, Knopp MV, Engenhart R, Wannenmacher M, 1996, "[Blood volume changes after the radiotherapy of the central nervous system]." Strahlenther Onkol 172, no. 10, 559-66 - 559-66.
  • Knopp MV, Bock M, 1996, "[The internet data highway. Are there radiologic applications?]." Radiologe 36, no. 1, 92-5 - 92-5.

1995

  • Knopp MV, Hoffmann U, Brix G, Hawighorst H, Junkermann HJ, van Kaick G, 1995, "[Fast MRI contrast medium dynamics for characterization of tumors. Experiences with functional MR-mammography]." Radiologe 35, no. 12, 964-72 - 964-72.
  • Wenz F, Baudendistel K, Wildermuth S, Hess T, Egelhof T, Forsting M, Schad LR, Knopp MV, 1995, "Quantifizierung der hemisphärischen Asymmetrie bei Fingerbewegung mit der funktionellen Magnetresonanztomographie." Klinische Neuroradiologie 5, no. 2, 53-60 - 53-60.
  • Hawighorst, H.; Schad, L.R.; Gademann, G.; Blüml, S. et al., 1995, "A 3D T1-weighted gradient-echo sequence for routine use in 3D radiosurgical treatment planning of brain metastases: first clinical results." European Radiology 5, no. 1, 19-25 - 19-25.
  • Sijens PE, Knopp MV, Brunetti A, Wicklow K, Alfano B, Bachert P, Sanders JA, Stillman AE, Kett H, Sauter R, et al, 1995, "1H MR spectroscopy in patients with metastatic brain tumors: a multicenter study.." Magn Reson Med 33, no. 6, 818-26 - 818-26.
  • Delorme S, Zuna I, Huber S, Albert B, Lohr F, Knopp MV, Junkermann H, van Kaick G, 1995, "Farb-Dopplersonographie bei Mammatumoren: Quantifizierung durch computergestutzte Verfahren.." Tumordiagn U Ther 16, 180-6 - 180-6.
  • Hawighorst H, Knapstein PG, Schaeffer U, Brix G, Weikel P, Essig M, Zuna I, Knopp MV, 1995, "[Diagnosis of recurrence of cervix carcinoma using dynamic MRI: correlation of pharmacokinetic analysis and histopathology]." Radiologe 35, no. 12, 945-51 - 945-51.
  • Knopp MV, Knopp MA, 1995, "[PC applications in routine practice, science and teaching. What computer peripherals are useful?]." Radiologe 35, no. 9, 620-4. Review - 620-4. Review.
  • Wenz F, Baudendistel K, Knopp MV, Schad LR, Schröder J, Flömer F, van Kaick G, 1995, "[Functional magnetic resonance tomography of movement disorders in patients with schizophrenia]." Radiologe 35, no. 4, 267-71 - 267-71.
  • Knopp, M.V.; Kauczor, H.U.; Knopp, M.A.; Manella, P. et al., 1995, "Influence of viscosity, cannula size and temperature in mechanical contrast medium application in CT and MRI." RoFo Fortschritte auf dem Gebiete der Rontgenstrahlen und der Neuen Bildgebenden Verfahren 163, no. 3, 259-264 - 259-264.
  • Schröder J, Wenz F, Schad LR, Baudendistel K, Knopp MV, 1995, "Sensorimotor cortex and supplementary motor area changes in schizophrenia. A study with functional magnetic resonance imaging." Br J Psychiatry 167, no. 2, 197-201 - 197-201.

1994

  • Niethammer R, Karr M, Schad LR, Knopp MV, Wenz F, Stockert A, Baudendistel K, Schroder J, 1994, "Schizophrene Psychosen. Morphologische und funktionelle Veränderungen." TW Neurologie Psychiatrie 8, 679-86 - 679-86.
  • Danes J, Knopp MV, Zuna I, van Kaick G, 1994, "MR mamografie (magnetická rezonance prsu). Historie a soucasnost." Ces Radiol 48, no. 2, 92-6 - 92-6.
  • Schlemmer HP, Hess T, Debus J, Knopp MV, Schad LR, Engenhart R, 1994, "[TOF-MR angiography in radiotherapy treated cerebral arteriovenous malformations]." Radiologe 34, no. 8, 447-53 - 447-53.
  • Knopp MV, 1994, "[CD-ROM for radiologic literature research]." Radiologe 34, no. 9, 557-60 - 557-60.
  • Ende G, Bachert P, Kolem H, Blankenhorn M, Semmler W, Knopp MV, Lorenz WJ, 1994, "Metabolische Bildgebung am Gehirn des Menschen mittels lokalisierter in vivo 31P-1H-Doppelresonanz-Spektroskopie." Z Med Phys 4, 14-20 - 14-20.
  • Hess T, Muller-Schimpfle M, Brix G, Junkermann H, Heiland S, Knopp MV, van Kaick G, Semmler W, 1994, "Dynamic Gd-DTPA Enhanced MRI in the Follow-Up of Cervical Carcinoma after Combined Radio/Chemotherapy." Adv MRI Contrast 2, no. 3-4, 85-93 - 85-93.
  • Betsch B, Berndt R, Knopp MV, Schmähl A, Trost U, Delorme S, 1994, "[Comparison of computerized tomography and B-image ultrasound in imaging diagnosis of the mediastinum]." Bildgebung 61, no. 4, 295-8 - 295-8.
  • Knopp MV, Hess T, Schad LR, Bischoff HG, Weisser G, Blüml S, van Kaick G, 1994, "[MR tomography of lung metastases with rapid gradient echo sequences. Initial results in diagnostic applications]." Radiologe 34, no. 10, 581-7 - 581-7.
  • Hawighorst, H.; Gademann, G.; Knopp, M.V.; Wannenmacher, W. et al., 1994, "High precision radiotherapy for 30 low grade gliomas: First results with emphasis on late delayed radiation injury depicted on magnetic resonance tomography." Tumor Diagnostik und Therapie 15, no. 4, 143-148 - 143-148.

1993

  • Schad LR, Trost U, Knopp MV, Müller E, Lorenz WJ, 1993, "Functional Magnetic Resonance Imaging of Motoric Stimulation Measured at 1.5 Tesla." Z Med Phys 3, 88-91 - 88-91.

1992

  • Schad, L.R.; Gademann, G.; Knopp, M.; Zabel, H.J. et al., 1992, "Radiotherapy treatment planning of basal meningiomas: improved tumor localization by correlation of CT and MR imaging data.." Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 25, no. 1, 56-62 - 56-62.
  • Knopp MV, Schönhofen H, Knopp A, 1992, "[A hepatic space-occupying lesion. Liver abscess due to a retained surgical towel]." Radiologe 32, no. 9, 451-2 - 451-2.
  • Gamroth AH, Schad LR, Wacker CM, Gehling U, Knopp MV, Betsch B, Clorius JH, van Kaick G, 1992, "[Measurement of the blood flow velocity in the pulmonary arteries using the magnetic resonance technique]." Radiologe 32, no. 4, 182-4 - 182-4.
  • Delorme S, Knopp MV, Kauczor HU, Zuna I, Trost U, Haberkorn U, van Kaick G, 1992, "[Recurrence paralysis: computed tomographic analysis of intrathoracic findings]." Radiologe 32, no. 9, 430-5 - 430-5.
  • Knopp MV, Bischoff H, Oberdorfer F, van Kaick G, 1992, "[Positron emission tomography of the thorax. The current clinical status]." Radiologe 32, no. 6, 290-5 - 290-5.
  • Gehling, U.; Knopp, M.; Saggau, W.; Schulz, V., 1992, "Aortopulmonary fistula formation after surgery of coarctation of the aorta as a rare cause of recurring hemoptyses." Pneumologie 46, no. 11, 587-590 - 587-590.

1991

  • Kauczor HU, Knopp MV, Delorme S, van Kaick G, 1991, "[Computed tomography of the upper mediastinum. Optimized contrast media application by the use of an infusion pump]." Rofo 155, no. 1, 46-52 - 46-52.

Presentations

  • "Changes of renal blood flow in nephroptosis: assessment by color Doppler imaging, isotope renography and correlation with clinical outcome after laparoscopic nephropexy.."
  • "Direct delayed human adenoviral BMP-2 or BMP-6 gene therapy for bone and cartilage regeneration in a pony osteochondral model."
  • "Direct delayed human adenoviral BMP-2 or BMP-6 gene therapy for bone and cartilage regeneration in a pony osteochondral model.."
  • "Direct Human Adenoviral BMP-2 or BMO-6 Gene Therapy for Bone and Cartilage Regeneration in a Pony Osteochondral Model." Presented at OSU Medical Center Annual Research Day,
  • "3D Activity Mapping of Yttrium-90 Interventional Radioembolization for Dose Verification using A Solid-state Digital PET Detector System." Presented at Society of Nuclear Medicine & Molecular Imaging (SNMMI) Annual Meeting 2015,
  • "Feasibility of Accelerating Yttrium-90 PET by Optimizing PET Volume Overlap." Presented at European Association of Nuclear Medicine (EANM) Annual Meeting 2015,
  • "Does Reducing Reconstruction Voxel Volume / Increasing Matrix Size Improve Lesion Detectability? A phantom and clinical feasibility demonstration using next generation digital PET/CT." Presented at European Association of Nuclear Medicine (EANM) Annual Meeting,
  • "Real-time Portable Gamma Camera Imaging for Optimizing Quality Control During Parenteral Radiotherapy Administration.." Presented at Society of Nuclear Medicine & Molecular Imaging (SNMMI) Annual Meeting 2015,
  • "Feasibility Demonstration of Imaging In Vivo Biodistribution of Yttrium-90 Microspheres After Radioembolization With a Digital Detector PET/CT System." Presented at Society of Nuclear Medicine & Molecular Imaging (SNMMI) Annual Meeting 2015,
  • "Phase I Trial comparing a Digital Detector PET/CT System with current photomultiplier PET Technology in Diagnostic Oncology.." Presented at European Association of Nuclear Medicine (EANM) Annual Meeting,
  • "Phase I Clinical Experience of Post-Radioembolization Yttrium-90 Imaging Using Next Generation Digital PET/CT." Presented at European Association of Nuclear Medicine (EANM) Annual Meeting 2015,
  • "Clinical Experience with Vereos Digital Photon Counting PET/CT system - a year in review." 2016, Presented at 32nd International Austrian Winter Symposium,
  • "Sumamry/Recommendations." 2001, Presented at Higher Field (1.5T & Up) in Oncology: Strategic Frontiers in Cancer Diagnosis and Treatment,
  • "Refresher Course: MR and CT Techniques in the Evaluation of Tumor Angiogenesis." 2001, Presented at Radiological Society of North America 2001 Annual Meeting,
  • "John K. Lattimer Lecture: Dynamic Contrast-Enhanced MRI." 2004, Presented at American Urological Association (AUA) 2004 Annual Meeting,
  • "Current Concepts in MR Based Therapy Assessment." 2004, Presented at ISMRM 12th Scientific Meeting,
  • "Clinical Challenges and Related Software/Informatics Requirements." 2004, Presented at Joint BECON/BISTIC Symposium 2004: Biomedical Informatics for Clinical Decision Support: A Vision for the 21st Century,
  • "Image-Based Clinical Trials: Requirements and Solutions - An Investigator's Perspective." 2004, Presented at CBI's 2nd Annual Medical Imaging for Clinical Trials,
  • "Guidelines and Recommendations." 2005, Presented at Berlex Multidisciplinary Advisory Board,
  • "Clinical and Economic Relevance." 2005, Presented at Berlex Multidisciplinary Advisory Board,
  • "Imaging - Its present and future for cancer diagnosis and clinical trials." 2005, Presented at AACR Inaugural Scientist-Survivor Program Educational Workshop,
  • ""Sites": Introduction, Context & Orientation." 2005, Presented at Philips 7T User Meeting,
  • "Special Symposium: Grant Writing: Opportunities, Needs and Strategies." 2006, Presented at ISMRM 14th Annual Meeting,
  • "Perspectives on high field and ultra-high field imaging." 2006, Presented at Philips Gold Corporate Member Lunchtime Symposia at ISMRM 14th Annual Meeting,
  • "Clinical Categorical Course: Therapy Assessment." 2006, Presented at ISMRM 14th Annual Meeting,
  • "Update on MR Contrast Agent Safety with Special Focus on NSF/NFD." 2007, Presented at The Ohio State University Medical Center,
  • "Opportunities and Requirements for CALGB in regard to caBIG In Vivo Imaging Workspace." 2007, Presented at caBIG In Vivo Imaging Workspace Face-to-Face Meeting,
  • "Imaging Needs in Renally Impaired Patients." 2007, Presented at American Society of Nephrology Annual Meeting,
  • "Gastrointestinal (CT/MR Perfusion: Liver)." 2007, Presented at Radiological Society of North America 2007 Annual Meeting,
  • "MRI Contrast Agents." 2008, Presented at 891.01 CESBMI (Comprehensive Engineering & Science of Biomedical Images) Seminar,
  • "Imaging and Targeted Therapy: Round Table Discussion." 2008, Presented at International Thoracic Oncology Congress Dresden,
  • "Imaging and Targeted Therapy: Imaging Trials in Thoracic Oncology." 2008, Presented at International Thoracic Oncology Congress Dresden,
  • "Cancer Center Investments in New Science: Biomarkers, Imaging and Tissue Banks." 2008, Presented at Association of American Cancer Institutes 2008 Annual Meeting,
  • "Future: Contrast agents - what is new?." 2009, Presented at Fifth International Congress on MR-Mammography,
  • "Challenges for Multi-Modality Mammography in large Medical Centers." 2009, Presented at Fifth International Congress on MR-Mammography,
  • "How functional/quantitative imaging and therapy response monitoring are enabling breakthroughs in care." 2011, Presented at Philips Champions in Radiology,
  • "Biomedical Imaging: Insight, Imagination and Innovation." 2011, Presented at Advances in Veterinary Medicine Research Week,
  • "Scientific Session: Monitoring Therapy." 2011, Presented at 2011 World Molecular Imaging Congress,
  • "RSNA/ACRIN Imaging Researchers Workshop: Informatics Tools in Support of Clinical and Translational Research: Integration of the Imaging Informatics Infrastructure within the Clinical and Translational Research Enterprise." 2011, Presented at ACRIN Annual Meeting,
  • "RSNA/ACRIN Imaging Researchers Workshop: Informatics Tools in Support of Clinical and Translational Research: Imaging Core Lab Workflow Management." 2011, Presented at ACRIN Annual Meeting,
  • "RSNA/ACRIN Imaging Researchers Workshop: Caveats and Pitfalls in Implementing an Imaging Core to Support Clinical and Translational Research: Funds Flow for Imaging Clinical Overreads and Research Data Extraction in Clinical Trials (Charging and Distribution)." 2011, Presented at ACRIN Annual Meeting,
  • "PET/MRI – Bringing a new imaging modality into clinical practice." 2012, Presented at 891.01 Comprehensive Engineering and Science of Biomedical Images (CESBMI) Seminar Series,
  • "Monitoring Oncologic Therapies: Current Concepts and Best Practices." 2012, Presented at University of Texas Medical Branch Cooley Visiting Professor Lecture,
  • "Imaging tumor perfusion in clinical trials." 2012, Presented at Annual International Thyroid Oncology (ITOG) 2012 Meeting,
  • "Imaging in Medicine: Innovation, Insight and Imagination." 2012, Presented at National Student Research Forum,
  • "Concepts and Opportunities in Perioperative Imaging." 2012, Presented at University of Texas Medical Branch Residents Clinical Research Review,
  • "Imaging approaches relevant for Regenerative Medicine and Cell-Based Therapies." 2012, Presented at Center for Regenerative Medicine and Cell Based Therapies (CRMCBT) 1st Annual Retreat,
  • "Panel I: Molecular and Clinical Oncology Perspective - High Field MR: A Molecular Biology Perspective." 2001, Presented at Higher Field (1.5T & Up) in Oncology: Strategic Frontiers in Cancer Diagnosis and Treatment,
  • "Panel I: Molecular and Clinical Oncology Perspective." 2001, Presented at Higher Field (1.5T & Up) in Oncology: Strategic Frontiers in Cancer Diagnosis and Treatment,
  • "Intraindividual Comparison of Contrast Enhancement in Brain Tumors: A Blinded Reader Comparison of a Standard Gd-chelate (Gd-DTPA) vs. a Weak Interacting (Gd-BOPTA)." 2001, Presented at ASNR 39th Annual Meeting,
  • "3D MR Colonography after Exclusive Intravenous Administration of a Hepatobiliary Contrast Agent." 2001, Presented at ASNR 39th Annual Meeting,
  • "Vascular MR Imaging: Facts & Challenges: Introduction: MR Contrast Agents: Capabilities and Choices." 2002, Presented at ISMRM 10th Scientific Meeting - Bracco Forum,
  • "Vascular MR Imaging: Facts & Challenges." 2002, Presented at ISMRM 10th Scientific Meeting - Bracco Forum,
  • "CNS MR Perfusion Imaging: What is it Today and What Can it be Tomorrow?." 2002, Presented at ASNR 40th Annual Meeting,
  • "Clinical Categorical Course: Current Clinical State of the Art: Dynamic Imaging for Functional Assessment." 2002, Presented at ISMRM 10th Scientific Meeting,
  • "Clinical Categorical Course: Current Clinical State of the Art." 2002, Presented at ISMRM 10th Scientific Meeting,
  • "Advanced MRA Techniques: Higher SNR Methods: MRA Contrast Agents." 2002, Presented at ISMRM 10th Scientific Meeting,
  • "Regulatory issues related to the introduction of new MRI agents." 2002, Presented at ISMRM MR of Cancer Study Group Workshop,
  • "Female Breast: Therapy-monitoring: Dynamic monitoring of anti-angiogenesis therapy for breast cancer." 2003, Presented at MR 2003 Garmisch: 10th International MRI Symposium,
  • "Refresher Course: MR and CT Techniques in the Evaluation of Tumor Angiogenesis." 2003, Presented at Radiological Society of North America 2003 Annual Meeting,
  • "Plenary Session: Early Predictors of Tumor Response, Questions and Panel Discussion." 2005, Presented at Radiological Society of North America 2005 Annual Meeting,
  • "Current Trends in MRI." 2007, Presented at 3rd Annual Magnetic Resonance Imaging Seminar,
  • "caBIG Imaging Workspace and Cooperative Clinical Research Session." 2007, Presented at caBIG Imaging Workspace and Cooperative Clinical Research Session,
  • "Scientific Session 2: General 1." 2009, Presented at Philips 7T User Meeting 2009,
  • "Micro-imaging: a link from in vivo to tissue." 2009, Presented at 891.01 CESBMI (Comprehensive Engineering & Science of Biomedical Images) Seminar,
  • "How to Make 7T Reimbursable: Issues for Patient Care and Clinical Trials." 2009, Presented at Philips 7T User Meeting 2009,
  • "DWI, MRS and beyond." 2009, Presented at Fifth International Congress on MR-Mammography,
  • "Breast MR Masterclass - Overview of Breast MRI." 2010, Presented at 2010 SMRT Annual Meeting,
  • "Plenary Speaker: Biomedical Research and Agricultural Research." 2010, Presented at The Ohio State University College of Veterinary Medicine Focus-Forward Weekend,
  • "Weekday Educational Course: MR Physics & Techniques for Clinicians: Contrast Agents." 2011, Presented at ISMRM 19th Scientific Meeting,
  • "Weekday Educational Course: Clinical Applications of Ultra-high Field 7T MR - Moving to FDA/EU Approval: Potential Clinical Applications for Ultra-High Field MRI." 2011, Presented at ISMRM 19th Scientific Meeting,
  • "Biomedical Imaging: Insight, Imagination and Innovation." 2011, Presented at BME 581/881 Seminar Series,
  • "Advanced imaging for cartilage: How can we evaluate cartilage better to determine." 2012, Presented at OSU Sports Medicine Cartilage Symposium 2012,
  • "Contrast Agents for Coronary MRA: Overview of MR Contrast Agents for Cardiac Applications." 2000, Presented at First International Workshop on Coronary MR and CT Angiography,
  • "MRI of the CNS: Future Perspectives for Contrast Enhancement in MRI." 2001, Presented at UK Radiological Congress 2001,
  • "Intraindividual Comparison of Different MR Contrast Agents for Multiphasic MR Angiography." 2001, Presented at Radiological Society of North America 2001 Annual Meeting,
  • "The Role of Nuclear Medicine in Treatment Monitoring and Treatment Planning: The Complementary Role of PET and MRI." 2002, Presented at SNM 2002 Mid-Winter Educational Symposium,
  • "Symposium on Pulmonary Embolism: Current Status of MRI in Pulmonary Imaging." 2002, Presented at 29th Annual Meeting and Scientific Sessions of the American College of Nuclear Medicine,
  • "Devices: Addressing the Challenges." 2002, Presented at Third National Forum on Biomedical Imaging in Oncology,
  • "Refresher Course: MR and CT Techniques in the Evaluation of Tumor Angiogenesis." 2002, Presented at Radiological Society of North America 2002 Annual Meeting,
  • "Plenary Lectures." 2003, Presented at Third International Congress on MR Mammography,
  • "Plenary Lecture: How to integrate MR mammography into a dedicated women's health service?." 2003, Presented at Third International Congress on MR Mammography,
  • "Plenary Lecture: Contrast agents for MR mammography: current status and on-going developments." 2003, Presented at Third International Congress on MR Mammography,
  • "Contrast Agents: Overview." 2003, Presented at MR Angio Club 2003,
  • "Clinical Categorical Course: Cancer Imaging." 2005, Presented at ISMRM 13th Scientific Meeting,
  • "Breast Imaging: Dynamic Contrast-Enhanced Techniques and Computer-Aided Diagnosis for Breast MRI." 2005, Presented at ISMRM 13th Scientific Meeting,
  • "Advanced Neuro MR: Brain MRI: Microcirculation/Angiogenesis." 2005, Presented at ISMRM 13th Scientific Meeting,
  • "Special Symposium: Magnetic Resonance in Clinical Trials: Rountable Discussion - Current Challenges and Possible Solutions." 2007, Presented at ISMRM 15th Annual Meeting,
  • "Translational Research in Bio-Imaging." 2007, Presented at IBGP-792: Introduction to Translational Biomedical Research,
  • "Pushing the Limits: The Contrast Agents." 2008, Presented at Visions for the Future of MRI,
  • "The Third Frontier's Worldwide Reach." 2009, Presented at 2009 BioOhio Annual Conference,
  • "Refresher Course: Update Course in Diagnostic Radiology Physics: Imaging Technologies in Oncology - Introduction. Imaging for Treatment Evaluation.." 2009, Presented at Radiological Society of North America 2009 Annual Meeting,
  • "Whole Body Imaging: Opportunities and Challenges." 2010, Presented at 891.01 CESBMI (Comprehensive Engineering & Science of Biomedical Images) Seminar,
  • "DCE MRI in oncology standardization & validation issues." 2012, Presented at ISMRM 20th Annual Meeting,
  • "Contrast Agents." 2012, Presented at ISMRM 20th Annual Meeting,
  • "Molecular Imaging." 2001, Presented at Breast Cancer Think Tank Retreat 2001,
  • "Tumor Vascular Imaging: From Bedside and Back Again." 2002, Presented at NIH CCR Grand Rounds,
  • "Vendor Presentation Forum: Advances in Contrast Enhanced MRI." 2002, Presented at Clinical Magnetic Resonance Society 2002 Annual Meeting,
  • "MRI in Therapy Monitoring." 2002, Presented at Clinical Magnetic Resonance Society 2002 Annual Meeting,
  • "MRI in Oncology." 2002, Presented at Clinical Magnetic Resonance Society 2002 Annual Meeting,
  • "MR Angiography - Technqiues, Tips and Protocols." 2002, Presented at Clinical Magnetic Resonance Society 2002 Annual Meeting,
  • "High Field MR >=3T, Current Status and Trends." 2002, Presented at Clinical Magnetic Resonance Society 2002 Annual Meeting,
  • "Plenary Lectures: Clinical Trials." 2006, Presented at ISMRM 14th Annual Meeting,
  • "How do contrast agents reflect pathology?." 2006, Presented at 4th International Congress on MR Mammography,
  • "Contrast agents for MR-Mammography: upcoming applications." 2006, Presented at 4th International Congress on MR Mammography,
  • "Applied image processing for characterization of disease and response assessment in clinical oncology." 2006, Presented at 9th Medical Image Computing and Computer Assisted Intervention (MICCAI) Conference,
  • "Dynamic contrast enhanced MR as an assessment tool of therapeutic response in oncological therapies." 2006, Presented at American Association of Pharmaceutical Scientists (AAPS) Annual Meeting,
  • "Opportunities in MR: Strategic Perspectives." 2007, Presented at Bayer Schering Pharma Diagnostic Imaging Workshop,
  • "Innovative Imaging Modalities." 2007, Presented at Thoracic CME Symposium,
  • "Imaging as a Biomarker to Assess Therapeutic Response: Where are we and where do we need to go?." 2007, Presented at Grand Rounds Speaker at Beth Israel Deaconess Medical Center,
  • "Plenary Lectures: Monitoring Treatment Response." 2007, Presented at ISMRM 15th Annual Meeting,
  • "Special Symposium: Magnetic Resonance in Clinical Trials." 2007, Presented at ISMRM 15th Annual Meeting,
  • "Categorial Course: Cardiovascular MRI: From Principles to Protocols: Current and Novel Contrast Agents for MRA." 2007, Presented at ISMRM 15th Annual Meeting,
  • "Scientific Program 2: High Field MRI and MRS." 2007, Presented at Philips 7T User Meeting,
  • "Dose-Response, DCE-MRI and Safety of Gd-chelates at 7T." 2007, Presented at Philips 7T User Meeting,
  • "Imaging Research and Facilities in Radiology." 2008, Presented at Davis Heart and Lung Research Institute Imaging Symposium,
  • "Sophisticated OSUMC Entrepreneurs." 2008, Presented at From Concept to Commercialization: Maximizing the Potential of Translational Research,
  • "Refresher Course: Update Course in Diagnostic Radiology Physics: Imaging Technologies in Oncology - Introduction: Imaging for Treatment Evaluation." 2008, Presented at Radiological Society of North America 2008 Annual Meeting,
  • "The Use of intravenous contrast in MRI." 2009, Presented at ISMRM 17th Scientific Meeting,
  • "Methods Workshop: Integrating Molecular Imaging with Biomarkers and Functional Measures." 2009, Presented at American Association for Cancer Research 100th Annual Meeting,
  • "Forum: Assessing Response Using Imaging to Determine Endpoints in Clinical Trials." 2009, Presented at American Association for Cancer Research 100th Annual Meeting,
  • "Plenary Keynote: Clinical Opportunities and Challenges for Cancer Imaging with Nanoparticles." 2010, Presented at 2010 WMIC Post-Congress Symposium,
  • "Novel Probes for Cancer Detection." 2010, Presented at 2010 World Molecular Imaging Congress,
  • "MR in Clinical Routine Assessment of Cancer Treatment." 2010, Presented at ISMRM MR of Cancer Study Group Workshop,
  • "How do we accelerate clinical utilization of 7T: Opportunities & Challenges." 2010, Presented at Philips 7T User Meeting 2010,
  • "Clinical MRI: How do we move beyond the visual interpretation? - Strategies & Challenges." 2010, Presented at ISMRM MR of Cancer Study Group Workshop,
  • "Advancing Cancer Research Through Imaging: Operational Strategies to Integrate Imaging Effectively into Clinical Cancer Research and Opportunities for Cancer Center Collaborations." 2010, Presented at 2010 AACI/CCAF Annual Meeting,
  • "CTSA Imaging Working Group Meeting: How to Get Clinical Trial Studies Read by Radiologists: Models and Reimbursements." 2010, Presented at Radiological Society of North America 2010 Annual Meeting,
  • "Applications of FDG/FLT PET for Targeted Therapies in Early Clinical Development." 2011, Presented at 112th American Society of Clinical Pharmacology & Therapeutics (ASCPT) Annual Meeting,
  • "Introducing High Field MRI and Novel Imaging Protocols into Oncology Clinical Trials." 2011, Presented at UC Denver C-TRIC Lecture,
  • "PET/CT: Capabilities and Expectations on Design, Quality and Performance - Today and in 5 Years." 2012, Presented at Philips PET/CT Seminar,
  • "The Role of Industrial and Academic Partnership (MOMIL)." 2016, Presented at 2016 World Molecular Imaging Congress,
  • "Introduction to biomedical imaging and visualization." 2013, Presented at Mathematical Challenges in Biomolecular/Biomedical Imaging and Visualization,
  • "Imaging in Medicine: Innovation, Insight and Imagination." 2013, Presented at ENGR 4891 Seminar,
  • "The Relationship Between Radiology and Molecular Imaging." 2013, Presented at 2013 World Molecular Imaging Congress,
  • "Clinical Applications of Quantitative DCE-MRI." 2013, Presented at Radiological Society of North America 2013 Annual Meeting,
  • "Current State of the Art in Neuroimaging with special focus on PET." 2013, Presented at OSU Neurology & Neurosurgery Grand Rounds,
  • "Visions for Digital PET/CT." 2013, Presented at Philips Healthcare AMI Advisory Board,
  • "How can UHF MRI become a specialty Neuroimaging Clinical Exam?." 2013, Presented at 9th Biennial 2013 Minnesota Workshop on High and Ultra-High Field Imaging,
  • "The IROC Grant and the Integrated Imaging Core Lab effort." 2013, Presented at ECOG-ACRIN May Meeting,
  • "Imaging Pharmaceuticals 2013: What do I need to know as a Radiologist?." 2013, Presented at Noon Conference,
  • "Advanced Neuroimaging: Frontiers and Capabilities for Clinical Application." 2013, Presented at 2013 American College of Veterinary Internal Medicine Forum,
  • "Clinical Potential of Molecular Imaging in Veterinary Medicine." 2013, Presented at 2013 American College of Veterinary Internal Medicine Forum,
  • "TBD." 2014, Presented at Visiting Professor for Radiology Residents Conference,
  • "Innovation in Clinical Radiology: Stagnation, Evolution or Revolution." 2014, Presented at Visiting Professor for Radiology Grand Rounds,
  • "From Imagination to Imaging: Tools for Regenerative Medicine." 2014, Presented at Center for Regenerative Medicine and Cell-based Therapies Scientific Retreat TED Talks,
  • "Evolution of MRI and the Latest in MR Imaging." 2014, Presented at 10th Annual OSU Wexner Medical Center MRI Conference,
  • "The future of collaboration between diagnostic imaging and radiation oncology in research." 2014, Presented at AAPM ORVC Spring Clinical Symposium,
  • "Advanced Neuroimaging Efforts at OSU." 2014, Presented at CNS Retreat,
  • "Vereos Digital PET/CT: A technology innovation that can redefine our vision for PET/CT." 2014, Presented at The Future of PET - Philips User Event at EANM 2014,
  • "Vereos Digital PET/CT: A technology innovation that can redefine our vision for PET/CT." 2014, Presented at Philips PET User Group Meeting,
  • "Clinical Applications of Quantitative DCE-MRI." 2014, Presented at 2014 RSNA Annual Meeting,
  • "Leaping Molecular Imaging Forward." 2014, Presented at Philips Key Opinion Leaders Event,
  • "Initial Clinical Experience using a Digital Solid State PET Detector PET/CT System for Oncologic Whole Body Imaging." 2015, Presented at ACNM Annual Meeting 2015,
  • "Quo Vadis Postprocessing." 2015, Presented at Philips ICAP Software Engineers Retreat,
  • "Initial experience with the solid state digital photon counting chip." 2015, Presented at Philips Corporate Research,
  • "Advanced Concepts in GU Oncologic Imaging." 2015, Presented at Genitourinary Oncology Grand Rounds,
  • "Redefining the clinical PET/CT acquisition by re-optimization of its components." 2015, Presented at 45th Annual Scientific Meeting of the Australian and New Zealand Society of Nuclear Medicine,
  • "Low dose PET Imaging for nutrition and metabolism studies." 2015, Presented at 45th Annual Scientific Meeting of the Australian and New Zealand Society of Nuclear Medicine,
  • "Molecular Imaging, Radiomics and Imaging Genomics." 2015, Presented at 5th Annual Meeting of the Society for Translational Oncology,
  • "Insight." 2015, Presented at 45th Annual Scientific Meeting of the Australian and New Zealand Society of Nuclear Medicine,
  • "Bringing a next generation technology into global healthcare: a vision, innovation and you." 2015, Presented at Philips Healthcare Town Hall Meeting,
  • "Redefining the clinical PET/CT acquisition by re-optimization of its components and first experience using a digital detector PET/CT." 2015, Presented at Australian and New Zealand Society of Nuclear Medicine New Zealand Branch Guest Speaker Presentations,
  • "Molecular Imaging to assess and monitor tissue proliferation by 18F-FLT PET/CT during investigational Breast Cancer Therapy." 2015, Presented at WMIC 2015,
  • "Technical and clinical innovations in PET." 2015, Presented at Philips Advanced Molecular Imaging Global User Event,
  • "First Experiences with Vereos Digital PET/CT." 2015, Presented at Philips Event at British Nuclear Medicine Society Spring Meeting 2015,
  • "Cancer Imaging Research: Framing the Future." 2015, Presented at ECOG-ACRING Spring 2015 Group Meeting,
  • "What is needed to bring 7T to the clinic? What’s needed for neuro?." 2015, Presented at ISMRM 2015,
  • "Digital Photon Counting: Initial Clinical Experience with the Next Generation PET/CT." 2015, Presented at SNMMI 2015,
  • "Overview of PET-CT and Other Functional Imaging in Oncology." 2015, Presented at NRG Oncology Seminannual Meeting,
  • "Central lab QA." 2015, Presented at National Biomarker Development Alliance (NBDA) Convergence Conference III: Standards for Biomarker Measurement using Diffusion Weighted MRI,
  • "Phase I Trial comparing a Digital Detector PET/CT System with current photomultiplier PET Technology in Diagnostic Oncology." 2015, Presented at EANM 2015,
  • "Clinical experience with high resolution 2 mm PET reconstructions: Ingenuity TF PET/CT and Vereos." 2015, Presented at Philips Advanced Molecular Imaging Global User Event,
  • "Managers of Molecular Imaging Laboratories Symposium at WMIC." 2015, Presented at WMIC 2015,
  • "Cost/workload issues for radiology departments." 2015, Presented at National Biomarker Development Alliance (NBDA) Convergence Conference III: Standards for Biomarker Measurement using Diffusion Weighted MRI,
  • "Imaging in Medicine: Innovation, Insight and Imagination." 2012, Presented at ENGR 4891 Seminar,
  • "Virtual Communication for Managing Clinical Trials." 2013, Presented at 2013 RTOG Semiannual Meeting,
  • "Current Concepts in Oncologic Imaging and Update on Capabilities at OSU." 2013, Presented at OSU College of Veterinary Medicine Comparative Oncology Signature Program Meeting,
  • "Contrast Agents." 2013, Presented at ISMRM 21st Annual Meeting,
  • "Contrast agent clinical applications." 2013, Presented at Radiology 8814 MRI Course,
  • "Clinical Trials in Radiology: from the concept to the peer review paper." 2010, Presented at 891.01 CESBMI (Comprehensive Engineering & Science of Biomedical Images) Seminar,
  • "The Alliance." 2012, Presented at ECOG-ACRIN Imaging Investigator Workshop,
  • "IROC Model." 2012, Presented at ECOG-ACRIN Imaging Investigator Workshop,
  • "Imaging as a biomarker." 2012, Presented at ECOG-ACRIN Imaging Investigator Workshop,
  • "High Tesla MR Imaging." 2012, Presented at 2012 Congress of Neurological Surgeons Annual Meeting,
  • "Biomedical Imaging: Insight, Imagination and Innovation." 2012, Presented at Biophysics Seminar Series,
  • "Biomedical Imaging: Visualizing Anatomy, Physiology and Pathophysiology in Vivo." 2010, Presented at Mechanical Engineering 888 Seminar Series,
  • "Feasibility demonstration of dynamic FDG PET to assess ACL graft viability after reconstructive surgery." Presented at Annual meeting of the Society of Nuclear Medicine and Molecular Imaging,
  • "Assessment of ACL graft viability by dynamic FDG PET: A phase 1 study." Presented at Annual Congress of the European Association of Nuclear Medicine,,
  • "Cortical Lesion Simulations in Specimen and In Vivo for Detection with Ultra High Field MRI [Abstract]." Presented at Americas Committee for Treatment and Research in Multiple Sclerosis 15th Annual Meeting,
  • "Real-time portable gamma camera imaging for optimizing quality control during parenteral radiotherapy administration."
  • "Phase I Clinical Experience of Post-Radioembolization Yttrium-90 Imaging Using Next Generation Digital PET/CT."
  • "Phase I Trial comparing a Digital Detector PET/CT System with current photomultiplier PET Technology in Diagnostic Oncology."
  • "3D Activity Mapping of Yttrium-90 Interventional Radioembolization for Dose Verification using A Solid-state Digital PET Detector System."
  • "Feasibility demonstration of imaging in vivo biodistribution of Yttrium-90 microspheres after radioembolization with a digital detector PET/CT system.."
  • "Does Reducing Reconstruction Voxel Volume / Increasing Matrix Size Improve Lesion Detectability? A phantom and clinical feasibility demonstration using next generation digital PET/CT."
  • "Assessment of ACL Graft Viability by Dynamic FDGPET: A Phase I Study."
  • "Feasibility of Accelerating Yttrium-90 PET by Optimizing PET Volume Overlap."
  • "Feasibility demonstration of dynamic FDG PET to assess ACL graft viability after reconstructive surgery."
  • "Cortical lesion simulations in specimen and in vivo for detection with ultra high field MRI."
  • "Real-time portable gamma camera imaging for optimizing quality control during parenteral radiotherapy administration." Presented at Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging,
  • "Phase I Clinical Experience of Post-Radioembolization Yttrium-90 Imaging Using Next Generation Digital PET/CT." Presented at 28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM),
  • "Phase I Trial comparing a Digital Detector PET/CT System with current photomultiplier PET Technology in Diagnostic Oncology." Presented at 28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM),
  • "3D Activity Mapping of Yttrium-90 Interventional Radioembolization for Dose Verification using A Solid-state Digital PET Detector System." Presented at Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging,
  • "Feasibility demonstration of imaging in vivo biodistribution of Yttrium-90 microspheres after radioembolization with a digital detector PET/CT system.." Presented at Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging,
  • "Does Reducing Reconstruction Voxel Volume / Increasing Matrix Size Improve Lesion Detectability? A phantom and clinical feasibility demonstration using next generation digital PET/CT." Presented at 28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM),
  • "Assessment of ACL Graft Viability by Dynamic FDGPET: A Phase I Study." Presented at 28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM),
  • "Feasibility of Accelerating Yttrium-90 PET by Optimizing PET Volume Overlap." Presented at 28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM),
  • "Feasibility demonstration of dynamic FDG PET to assess ACL graft viability after reconstructive surgery." Presented at Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging,
  • "Cortical lesion simulations in specimen and in vivo for detection with ultra high field MRI." Presented at 15th Annual Meeting of the Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis,
  • "Insight.."
  • "Insight."

Papers in Proceedings

2017

  • Zhang, J.; Wright, C.; Bhatia, P.; Binzel, K. et al. "Advantage and Clinical Benefit of 325ps TOF PET for Lesion Detectability." (1 2017).
  • Zhang, J.; Maniawski, P.; Knopp, M.V. "Effect of next generation SiPM digital photon counting PET technology on effective system spatial resolution." (1 2017).
  • Krishna, V.; Hargrove, A.; Agrawal, P.; Changizi, B. et al. "A novel tractography-based targeting method for focused ultrasound thalamotomy: Clinical outcomes." in Annual Scientific Meeting of the American-Association-of-Neurological-Surgeons (AANS). (4 2017).
  • Zhang, J.; Binzel, K.; Knopp, M.V. "Next-generation Brain PET - Current Observations and Future Trends." (1 2017).
  • Krishna, V.; Hargrove, A.; Agrawal, P.; Changizi, B. et al. "A novel tractography-based targeting method for focused ultrasound thalamotomy: Clinical outcomes." (4 2017).
  • Zhang, J.; Binzel, K.; Friel, M.; Knopp, M. et al. "Next-generation brain PET - Current observations and future trends." (5 2017).
  • Zhang, J.; Friel, M.; Sanchez, V.; Zhang, B. et al. "Impact of PSF regularization on clinical PET image quality." (1 2017).
  • Zhang, J.; Maniawski, P.; Knopp, M. "Effect of next generation SiPM digital photon counting PET technology on effective system spatial resolution." (5 2017).
  • Zhang, J.; Wright, C.; Bhatia, P.; Binzel, K. et al. "Advantage and clinical benefit of 325ps TOF PET for lesion detectability." in Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI). (5 2017).
  • Zhang, J.; Binzel, K.; Friel, M.; Knopp, M. et al. "Next-generation brain PET - Current observations and future trends." in Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI). (5 2017).
  • Zhang, J.; Maniawski, P.; Knopp, M. "Effect of next generation SiPM digital photon counting PET technology on effective system spatial resolution." in Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI). (5 2017).
  • Zhang, J.; Wright, C.; Bhatia, P.; Binzel, K. et al. "Advantage and clinical benefit of 325ps TOF PET for lesion detectability." (5 2017).

2016

  • Knopp, M.V.; Briley, K.; Menendez, M.I.; Williams, M. et al. "High Throughput Rodent Imaging Using a Clinical Digital PET/CT System." (10 2016).
  • Knopp, M.V.; Binzel, K.; Siva, A.; Moore, R. et al. "A Paradigm Shift in PET Imaging Reconstruction Inspired by Digital PET." (10 2016).
  • Knopp, M.I.; Odom, C.; Binzel, K.; Wright, C.L. et al. "Use of Ultra-Portable Ultrasound to Improve IV Access for Nuclear Medicine Dose Administration." (10 2016).
  • Zhang, J.; Binzel, K.; Miller, M.; Knopp, M.V. "Evaluation of System Characteristics of Next Generation Digital Photon Counting Compared to Current Photomultiplier Tube PET/CT." (10 2016).
  • Knopp, M.M.; Milacek, J.; Knopp, M.I.; Binzel, K. et al. "How Can We Use Digital Programmable LED Lighting in a Nuclear Medicine Environment?." (10 2016).
  • Zhang, J.; Wright, C.L.; Siva, A.; Bhatia, P. et al. "Ultra-High Definition Digital PET for Hepatic Malignancies and Metastases." (10 2016).
  • Binzel, K.; Siva, A.; Saif, T.; Lehn, C. et al. "Impact of PSF and Gaussian Filtering on SUV Assessment - A Clinical Study Using Digital PET." (10 2016).
  • Menendez, M.I.; Wei, L.; Knopp, M. "CORRELATION BETWEEN 18F-FDG AND F-18 SODIUM FLUORIDE (NAF) PET/MRI AND GROSS MORPHOLOGY OF THE KNEE IN A CANINE MODEL OF OSTEOARTHRITIS.." (4 2016).
  • Wright, C.L.; Binzel, K.; Zhang, J.; Wuthrick, E. et al. "Advancing Post-Radioembolization Yttrium-90 Imaging: The Clinical Impact of Time-of-Flight in Next-Generation Digital PET/CT versus Conventional PET/CT Systems." (10 2016).
  • Zhang, J.; Hall, N.C.; Schoder, H.; Schwartz, L.P. et al. "The Oncology Biomarker Qualification Initiative (OBQI): Multi-institutional Demonstration Using FDG-PET in Non-Hodgkin's Lymphoma." in Annual Congress of the European-Association-of-Nuclear-Medicine (EANM). (10 2016).
  • Odom, C.I.; Wright, C.L.; Subramanian, P.; Zhang, J. et al. "Quantitative Assessment of Osteoblastic Tumor Burden with Threshold-based Volumetric (NaF)-F-18 PET/CT Methodologies - Challenges and Opportunities." (10 2016).
  • Wright, C.L.; Binzel, K.; Zhang, J.; Jedlicka, M. et al. "Assessing Yttrium-90 Microsphere Delivery Systems Following Radioembolization: A Feasibility Study Using Digital Photon Counting PET/CT Technology." (10 2016).
  • Liu, X.; Zhang, J.; Subramanian, P.; Ramaswamy, B. et al. "The Impact of Time-of-Flight Acquisition on Shortened Dynamic 18F-FLT PET Quantification." (10 2016).
  • Binzel, K.; Revan, R.; Zhang, J.; Scharre, D. et al. "PET for Neurology: Short Acquisition Neuro-PET Enabled by Digital Photon Counting." (10 2016).
  • Binzel, K.; Moore, R.; Liu, X.; Knopp, M.U. et al. "Feasibility of Ultra High Definition Dynamic PET/MR for Evaluation of ACL Graft Viability." (10 2016).
  • Wright, C.L.; Bhatt, A.D.; Binzel, K.; Bhatia, P. et al. "Advancing Precision Nuclear Medicine for Head and Neck Cancers with Higher Definition Digital PET/CT." (10 2016).
  • Subramanian, P.; Binzel, K.; Bhatia, P.; Ramaswamy, B. et al. "Should the PET Reconstruction be Optimized in a DifferentWay for F-18-FLT?." (10 2016).
  • Knopp, M.V.; Binzel, K.; Siva, A.; Moore, R. et al. "A Paradigm Shift in PET Imaging Reconstruction Inspired by Digital PET." in Annual Congress of the European-Association-of-Nuclear-Medicine. (10 2016).
  • Menendez, M.I.; Hettlich, B.; Wei, L.; Knopp, M.V. "Canine NaF-18 PET/CT: Knee Assessment Using an Old Skeletal Radiotracer." in Annual Congress of the European-Association-of-Nuclear-Medicine (EANM). (10 2016).
  • Wright, C.L.; Binzel, K.; Zhang, J.; Wuthrick, E. et al. "Advancing Post-Radioembolization Yttrium-90 Imaging: The Clinical Impact of Time-of-Flight in Next-Generation Digital PET/CT versus Conventional PET/CT Systems." in Annual Congress of the European-Association-of-Nuclear-Medicine (EANM). (10 2016).
  • Knopp, M.I.; Odom, C.; Binzel, K.; Wright, C.L. et al. "Use of Ultra-Portable Ultrasound to Improve IV Access for Nuclear Medicine Dose Administration." in Annual Congress of the European-Association-of-Nuclear-Medicine (EANM). (10 2016).
  • Odom, C.I.; Wright, C.L.; Subramanian, P.; Zhang, J. et al. "Quantitative Assessment of Osteoblastic Tumor Burden with Threshold-based Volumetric (NaF)-F-18 PET/CT Methodologies - Challenges and Opportunities." in Annual Congress of the European-Association-of-Nuclear-Medicine (EANM). (10 2016).
  • Wright, C.L.; Binzel, K.; Zhang, J.; Jedlicka, M. et al. "Assessing Yttrium-90 Microsphere Delivery Systems Following Radioembolization: A Feasibility Study Using Digital Photon Counting PET/CT Technology." in Annual Congress of the European-Association-of-Nuclear-Medicine (EANM). (10 2016).
  • Hall, N.C.; Wright, C.L.; Gortanla, N.; Nagar, V. et al. "Matched Pair Validation of Ultra-low-dose CT Compared to Low-dose CT for Oncologic F-18-FDG PET/CT." in Annual Congress of the European-Association-of-Nuclear-Medicine. (10 2016).
  • Friedberg, J.W.; Li, H.; Schoder, H.; Straus, D. et al. "LONG-TERM FOLLOW-UP OF SWOG S0816: RESPONSE-ADAPTED THERAPY OF ADVANCED STAGE HODGKIN LYMPHOMA USING EARLY INTERIM FDG-PET IMAGING." in 10th International Symposium on Hodgkin Lymphoma. (10 2016).
  • Menendez, M.I.; Zhang, J.; Binzel, K.; Siva, A. et al. "Feasibility of Ultra-low Dose Canine Imaging Using a Next Generation Digital PET System." in Annual Congress of the European-Association-of-Nuclear-Medicine (EANM). (10 2016).
  • Binzel, K.; Revan, R.; Zhang, J.; Scharre, D. et al. "PET for Neurology: Short Acquisition Neuro-PET Enabled by Digital Photon Counting." in Annual Congress of the European-Association-of-Nuclear-Medicine (EANM). (10 2016).
  • Wright, C.L.; Bhatt, A.D.; Binzel, K.; Bhatia, P. et al. "Advancing Precision Nuclear Medicine for Head and Neck Cancers with Higher Definition Digital PET/CT." in Annual Congress of the European-Association-of-Nuclear-Medicine (EANM). (10 2016).
  • Zhang, J.; Binzel, K.; Miller, M.; Knopp, M.V. "Evaluation of System Characteristics of Next Generation Digital Photon Counting Compared to Current Photomultiplier Tube PET/CT." in Annual Congress of the European-Association-of-Nuclear-Medicine (EANM). (10 2016).
  • Knopp, M.M.; Milacek, J.; Knopp, M.I.; Binzel, K. et al. "How Can We Use Digital Programmable LED Lighting in a Nuclear Medicine Environment?." in Annual Congress of the European-Association-of-Nuclear-Medicine. (10 2016).
  • Miller, E.D.; Yang, X.; Abduljalil, A.; Knopp, M. et al. "Evaluation of Tumor Microenvironment Changes in Hepatocellular Carcinoma After Stereotactic Body Radiation Therapy Using Functional Magnetic Resonance Imaging." (10 2016).
  • Knopp, M.V.; Briley, K.; Menendez, M.I.; Williams, M. et al. "High Throughput Rodent Imaging Using a Clinical Digital PET/CT System." in Annual Congress of the European-Association-of-Nuclear-Medicine. (10 2016).
  • Menendez, M.I.; Zhang, J.; Binzel, K.; Siva, A. et al. "Feasibility of Ultra-low Dose Canine Imaging Using a Next Generation Digital PET System." (10 2016).
  • Binzel, K.; Moore, R.; Liu, X.; Knopp, M.U. et al. "Feasibility of Ultra High Definition Dynamic PET/MR for Evaluation of ACL Graft Viability." in Annual Congress of the European-Association-of-Nuclear-Medicine (EANM). (10 2016).
  • Subramanian, P.; Binzel, K.; Bhatia, P.; Ramaswamy, B. et al. "Should the PET Reconstruction be Optimized in a DifferentWay for F-18-FLT?." in Annual Congress of the European-Association-of-Nuclear-Medicine (EANM). (10 2016).
  • Binzel, K.; Siva, A.; Saif, T.; Lehn, C. et al. "Impact of PSF and Gaussian Filtering on SUV Assessment - A Clinical Study Using Digital PET." in Annual Congress of the European-Association-of-Nuclear-Medicine (EANM). (10 2016).
  • Menendez, M.I.; Wei, L.; Knopp, M. "CORRELATION BETWEEN 18F-FDG AND F-18 SODIUM FLUORIDE (NAF) PET/MRI AND GROSS MORPHOLOGY OF THE KNEE IN A CANINE MODEL OF OSTEOARTHRITIS.." in World Congress of the Osteoarthritis-Research-Society-International (OARSI) on Osteoarthritis. (4 2016).
  • Menendez, M.I.; Hettlich, B.; Wei, L.; Knopp, M.V. "Canine NaF-18 PET/CT: Knee Assessment Using an Old Skeletal Radiotracer." (10 2016).
  • Zhang, J.; Miller, M.; Knopp, M.V. "Performance Evaluation of Digital PET/CT: Medical Physics Basis for the Clinical Applications." in 58th Annual Meeting and Exhibition of the American-Association-of-Physicists-in-Medicine (AAPM). (6 2016).
  • Followill, D.; Galvin, J.; Michalski, J.; Rosen, M. et al. "SU-F-T-237: The Imaging and Radiation Oncology Core (IROC) Cooperatives Activities Supporting the NCI's National Clinical Trial Network.." (6 2016).
  • Zhang, J.; Natwa, M.; Hall, N.C.; Knopp, M.U. et al. "Evaluate and Optimize PET Acquisition Overlap in 18F-FDG Oncology Wholebody PET/CT: Can We Scan PET Faster?." (6 2016).
  • Followill, D.; Galvin, J.; Michalski, J.; Rosen, M. et al. "The Imaging and Radiation Oncology Core (IROC) Cooperatives Activities Supporting the NCI's National Clinical Trial Network." in 58th Annual Meeting and Exhibition of the American-Association-of-Physicists-in-Medicine (AAPM). (6 2016).
  • Friedberg, J.W.; Li, H.; Schoder, H.; Straus, D. et al. "LONG-TERM FOLLOW-UP OF SWOG S0816: RESPONSE-ADAPTED THERAPY OF ADVANCED STAGE HODGKIN LYMPHOMA USING EARLY INTERIM FDG-PET IMAGING." (10 2016).
  • Hall, N.C.; Wright, C.L.; Gortanla, N.; Nagar, V. et al. "Matched Pair Validation of Ultra-low-dose CT Compared to Low-dose CT for Oncologic F-18-FDG PET/CT." (10 2016).
  • Zhang, J.; Hall, N.C.; Schoder, H.; Schwartz, L.P. et al. "The Oncology Biomarker Qualification Initiative (OBQI): Multi-institutional Demonstration Using FDG-PET in Non-Hodgkin's Lymphoma." (10 2016).
  • Followill, D.; Galvin, J.; Michalski, J.; Rosen, M. et al. "The Imaging and Radiation Oncology Core (IROC) Cooperatives Activities Supporting the NCI's National Clinical Trial Network." (6 2016).
  • Zhang, J.; Miller, M.; Knopp, M.V. "Performance Evaluation of Digital PET/CT: Medical Physics Basis for the Clinical Applications." (6 2016).
  • Zhang, J.; Wright, C.L.; Binzel, K.M.; Wuthrick, E.J. et al. "Feasibility of Accelerating Yttrium-90 PET by Optimizing PET Volume Overlap." (1 2016).
  • Zhang, J, Miller, M, Binzel, K, Tung, C, Knopp, MV "Evaluation of Stability and System Characteristics of Digital Photon Counting PET/CT." (5 2016).
  • Zhang, J.; Hall, N.C.; Schoder, H.; Poon, D. et al. "A Multi-Institutional Biomarker Study of Large B-cell Lymphomas in FDG PET/CT - Experiences within the Oncology Biomarker Qualification Initiative (OBQI)." (1 2016).
  • Zhang, J.; Miller, M.; Binzel, K.; Tung, C. et al. "Evaluation of the Stability and System Characteristics of Digital Photon Counting PET/CT." (5 2016).
  • Zhang, J.; Binzel, K.; Hall, N.C.; Natwa, M. et al. "Feasibility of Low Dose 18FDG PET in Pediatric Oncology Patients." (6 2016).
  • Zhang, J.; Binzel, K.; Hall, N.C.; Natwa, M. et al. "Feasibility of Low Dose 18FDG PET in Pediatric Oncology Patients." in 58th Annual Meeting and Exhibition of the American-Association-of-Physicists-in-Medicine (AAPM). (6 2016).
  • Ahn, D.H.; Ahn, C.; Nagar, V.; Noonan, A.M. et al. "Comprehensive analysis of radiographic, clinical, and inflammatory markers demonstrating changes in lean muscle correlate with outcome in patients (pts) with metastatic pancreatic adenocarcinoma (mPDAC) who undergo taxane-based chemotherapy (CT).." (2 2016).
  • Zhang, J.; Natwa, M.; Hall, N.C.; Knopp, M.U. et al. "Evaluate and Optimize PET Acquisition Overlap in 18F-FDG Oncology Wholebody PET/CT: Can We Scan PET Faster?." in 58th Annual Meeting and Exhibition of the American-Association-of-Physicists-in-Medicine (AAPM). (6 2016).
  • Miller, E.D.; Yang, X.; Abduljalil, A.; Knopp, M. et al. "Evaluation of Tumor Microenvironment Changes in Hepatocellular Carcinoma After Stereotactic Body Radiation Therapy Using Functional Magnetic Resonance Imaging." in 58th Annual Meeting of the American-Society-for-Radiation-Oncology. (10 2016).
  • Liu, X.; Zhang, J.; Subramanian, P.; Ramaswamy, B. et al. "The Impact of Time-of-Flight Acquisition on Shortened Dynamic 18F-FLT PET Quantification." in Annual Congress of the European-Association-of-Nuclear-Medicine. (10 2016).
  • Ahn, D.H.; Ahn, C.; Nagar, V.; Noonan, A.M. et al. "Comprehensive analysis of radiographic, clinical, and inflammatory markers demonstrating changes in lean muscle correlate with outcome in patients (pts) with metastatic pancreatic adenocarcinoma (mPDAC) who undergo taxane-based chemotherapy (CT).." in Gastrointestinal Cancers Symposium. (2 2016).
  • Zhang, J.; Wright, C.L.; Siva, A.; Bhatia, P. et al. "Ultra-High Definition Digital PET for Hepatic Malignancies and Metastases." in Annual Congress of the European-Association-of-Nuclear-Medicine. (10 2016).

2015

  • Miller, M.; Zhang, J.; Binzel, K.; Griesmer, J. et al. "Characterization of the Vereos Digital Photon Counting PET System." in Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging. (5 2015).
  • Miller, M.; Zhang, J.; Binzel, K.; Griesmer, J. et al. "Characterization of the Vereos Digital Photon Counting PET System." (5 2015).
  • Menendez, M.; Williams, M.; Clark, D.; Hettlich, B. et al. "MICRO-CT BONE STRUCTURE EVALUATION IN THE POND-NUKI DOG MODEL." (4 2015).
  • Menendez, M.; Clark, D.; Binzel, K.; Hettlich, B. et al. "F-18-SODIUM FLUORIDE (NAF) PET-CT AND CO-REGISTERED MRI KNEE ASSESSMENT AFTER ACL TRANSECTION IN AN IN VIVO CANINE MODEL." in World Congress of the Osteoarthritis-Research-Society-International (OARSI) on Osteoarthritis. (4 2015).
  • Zhang, J, Binzel, K, Bardos, P, Nagar, V, Knoppm M, Zhang, B, Hu, Z, Maniawski, P, Knopp, MV "FDG Dose Reduction Potential of a Next Generation Digital Detector PET/CT System: Initial Clinical Demonstration in Wholebody Imaging." (5 2015).
  • Zhang, J.; Binzel, K.; Bardos, P.; Nagar, V. et al. "FDG Dose Reduction Potential of a Next Generation Digital Detector PET/CT System: Initial Clinical Demonstration in Wholebody Imaging." (5 2015).
  • Hall, N.; Nagar, V.; Robertson, M.; Knopp, M. et al. "A qualitative SPECT/CT assessment of intratumoral Tc-99m-macroaggregated albumin in predicting response to liver radioembolization with Y-90 microspheres." (5 2015).
  • Menendez, M.; Clark, D.; Binzel, K.; Hettlich, B. et al. "F-18-SODIUM FLUORIDE (NAF) PET-CT AND CO-REGISTERED MRI KNEE ASSESSMENT AFTER ACL TRANSECTION IN AN IN VIVO CANINE MODEL." (4 2015).
  • Hall, N.; Nagar, V.; Robertson, M.; Knopp, M. et al. "A qualitative SPECT/CT assessment of intratumoral Tc-99m-macroaggregated albumin in predicting response to liver radioembolization with Y-90 microspheres." in Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging. (5 2015).
  • Villalona, M.; Lam, E.; Otterson, G.; Zhao, W. et al. "Oncolytic Reovirus in Combination with Paclitaxel/Carboplatin in NSCLC Patients with Ras Activated Malignancies, Long Term Results." (9 2015).
  • Menendez, M.; Clark, D.; Binzel, K.; Hettlich, B. et al. "18F-FDG PET-CT AND MRI CO-REGISTERED KNEE ASSESSMENT AFTER ACL TRANSECTION IN AN IN VTVO CANINE MODEL." in World Congress of the Osteoarthritis-Research-Society-International (OARSI) on Osteoarthritis. (4 2015).
  • Williams, M.; Christoforidis, J.; Kumar, K.; Briley, K. et al. "Intravitreal Imaging of I-124 Radiolabled bevacizumab, ranibizumab and aflibercept in a rabbit model with PET-CT." in Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging. (5 2015).
  • Menendez, M.; Williams, M.; Briley, K.; Knopp, M. "Feasibility of Na F-18 Micro-PET/CT Assessment in a Canine Model of Osteoarthritis." in Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging. (5 2015).
  • Christoforidis, J.B.; Williams, M.; Epitropoulos, F.M.; Knopp, M.V. "Anatomic and pharmacokinetic properties of bevacizumab, ranibizumab and aflibercept following intravitreal injection in a rabbit model." in Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO). (6 2015).
  • Villalona, M.; Lam, E.; Otterson, G.; Zhao, W. et al. "Oncolytic Reovirus in Combination with Paclitaxel/Carboplatin in NSCLC Patients with Ras Activated Malignancies, Long Term Results." (9 2015).
  • Binzel, K.; Zhang, J.; Zhang, B.; Hu, Z. et al. "How Does Increasing the Matrix Size / Reducing Voxel Volume Impact Quantification in FDG PET? A Detailed Analysis for Optimizing the Clinical Utility of Next Generation Digital PET/CT." (10 2015).
  • Menendez, M.; Williams, M.; Briley, K.; Knopp, M. "Feasibility of Na F-18 Micro-PET/CT Assessment in a Canine Model of Osteoarthritis." (5 2015).
  • Binzel, K.; Zhang, J.; Zhang, B.; Hu, Z. et al. "How Does Increasing the Matrix Size / Reducing Voxel Volume Impact Quantification in FDG PET? A Detailed Analysis for Optimizing the Clinical Utility of Next Generation Digital PET/CT." in 28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM). (10 2015).
  • Williams, M.; Christoforidis, J.; Kumar, K.; Briley, K. et al. "Intravitreal Imaging of I-124 Radiolabled bevacizumab, ranibizumab and aflibercept in a rabbit model with PET-CT." (5 2015).
  • Christoforidis, J.B.; Williams, M.; Epitropoulos, F.M.; Knopp, M.V. "Anatomic and pharmacokinetic properties of bevacizumab, ranibizumab and aflibercept following intravitreal injection in a rabbit model." (6 2015).
  • Rezai, A.R.; Mysiw, W.; Knopp, M.; Sederberg, P. et al. "Deep Brain Stimulation for Moderate and Severe Disability Due to Traumatic Brain Injury (TBI)." (6 2015).
  • Menendez, M.; Williams, M.; Clark, D.; Hettlich, B. et al. "MICRO-CT BONE STRUCTURE EVALUATION IN THE POND-NUKI DOG MODEL." in World Congress of the Osteoarthritis-Research-Society-International (OARSI) on Osteoarthritis. (4 2015).
  • Rezai, A.R.; Mysiw, W.; Knopp, M.; Sederberg, P. et al. "Deep Brain Stimulation for Moderate and Severe Disability Due to Traumatic Brain Injury (TBI)." in 83rd Annual Scientific Meeting of the American-Association-of-Neurological-Surgeons. (6 2015).
  • Menendez, M.; Clark, D.; Binzel, K.; Hettlich, B. et al. "18F-FDG PET-CT AND MRI CO-REGISTERED KNEE ASSESSMENT AFTER ACL TRANSECTION IN AN IN VTVO CANINE MODEL." (4 2015).

2014

  • Zhang, J.; Tung, C-H.; Zhang, B.; Hall, N. et al. "Reexamining PET volume overlap without impacting imaging quality: Setting the stage for faster acquisition in digital time-of-flight PET." in Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI). (5 2014).
  • Zhang, J.; Tung, C-H.; Zhang, B.; Hall, N. et al. "Reexamining PET volume overlap without impacting imaging quality: Setting the stage for faster acquisition in digital time-of-flight PET." in Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI). (5 2014).
  • Zhang, J.; Hall, N.; Binzel, K.; Natwa, M. et al. "Re-optimizing acquisition protocols for digital PET/CT: What have we learned to do it?." in Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI). (5 2014).
  • Binzel, K.; Zhang, J.; Liu, X.; Layman, R. et al. "Impact of current technologies (TOF, PSF, solid state detector) on the quantitative accuracy of PET/CT." in Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI). (5 2014).
  • Nayal, O.; Zhang, J.; Rezai, A.; Knopp, M. "Application of principal component analysis in dynamic 18F-FDG PET/CT neuroimaging of patients undergoing deep brain stimulation." in Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI). (5 2014).
  • Collier, K.; Zhang, J.; Binzel, K.; Hall, N. et al. "Neuroimaging PET tracers: An atlas based approach for comparison in NHP PET/CT." in Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI). (5 2014).
  • Binzel, K.; Zhang, J.; Hall, N.; Knopp, M. "The impact of time-of-flight acquisition on PET/CT standardized uptake values." in Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI). (5 2014).
  • Zhang, J, Tung, C, Zhang, B, Hall, NC, Liu, X, Knopp, M, Natwa, M, Shao, L, Knopp, MV "Reexamining PET volume overlap without impacting image quality: setting the stage for faster acquisition in digital time-of-flight PET." (5 2014).
  • Liu, X.; Zhang, J.; Ramaswamy, B.; Subramanian, P. et al. "How long a dynamic PET acquisition is needed for quantification of 18F-FLT kinetics in breast cancer?." in Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI). (5 2014).
  • Nayal, O.; Zhang, J.; Rezai, A.; Knopp, M. "Application of principal component analysis in dynamic 18F-FDG PET/CT neuroimaging of patients undergoing deep brain stimulation." in Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI). (5 2014).
  • Binzel, K.; Zhang, J.; Liu, X.; Layman, R. et al. "Impact of current technologies (TOF, PSF, solid state detector) on the quantitative accuracy of PET/CT." in Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI). (5 2014).
  • Grecula, J.C.; Elias, S.; Thelen, K.; Knopp, M. et al. "Dynamic-Contrast Enhanced MR and Volume Regression Rate as a Preoperative Predictive Assay in Patients With Non-Small Cell Lung Cancer." in 56th Annual Meeting of the American-Society-for-Radiation-Oncology. (9 2014).
  • Knopp, M.; Zhang, J.; Binzel, K.; Liu, X. et al. "Ultra-low dose FDG PET imaging for nutrition and metabolism studies." in Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI). (5 2014).
  • Zhang, J.; Tung, C-H.; Zhang, B.; Hall, N. et al. "Reexamining PET volume overlap without impacting imaging quality: Setting the stage for faster acquisition in digital time-of-flight PET." (5 2014).
  • Zhang, J.; Hall, N.; Binzel, K.; Natwa, M. et al. "Re-optimizing acquisition protocols for digital PET/CT: What have we learned to do it?." (5 2014).
  • Binzel, K.; Zhang, J.; Liu, X.; Layman, R. et al. "Impact of current technologies (TOF, PSF, solid state detector) on the quantitative accuracy of PET/CT." (5 2014).
  • Zhang, J.; Tung, C-H.; Zhang, B.; Hall, N. et al. "Reexamining PET volume overlap without impacting imaging quality: Setting the stage for faster acquisition in digital time-of-flight PET." (5 2014).
  • Knopp, M.; Zhang, J.; Binzel, K.; Liu, X. et al. "Ultra-low dose FDG PET imaging for nutrition and metabolism studies." (5 2014).
  • Binzel, K.; Zhang, J.; Hall, N.; Knopp, M. "The impact of time-of-flight acquisition on PET/CT standardized uptake values." (5 2014).
  • Collier, K.; Zhang, J.; Binzel, K.; Hall, N. et al. "Neuroimaging PET tracers: An atlas based approach for comparison in NHP PET/CT." (5 2014).
  • Binzel, K.; Zhang, J.; Liu, X.; Layman, R. et al. "Impact of current technologies (TOF, PSF, solid state detector) on the quantitative accuracy of PET/CT." (5 2014).
  • Liu, X.; Zhang, J.; Ramaswamy, B.; Subramanian, P. et al. "How long a dynamic PET acquisition is needed for quantification of 18F-FLT kinetics in breast cancer?." (5 2014).
  • Grecula, J.C.; Elias, S.; Thelen, K.; Knopp, M. et al. "Dynamic-Contrast Enhanced MR and Volume Regression Rate as a Preoperative Predictive Assay in Patients With Non-Small Cell Lung Cancer." (9 2014).
  • Nayal, O.; Zhang, J.; Rezai, A.; Knopp, M. "Application of principal component analysis in dynamic 18F-FDG PET/CT neuroimaging of patients undergoing deep brain stimulation." (5 2014).
  • Nayal, O.; Zhang, J.; Rezai, A.; Knopp, M. "Application of principal component analysis in dynamic 18F-FDG PET/CT neuroimaging of patients undergoing deep brain stimulation." (5 2014).

2013

  • Followill, D.; Knopp, M.; Galvin, J.; Fitzgerald, T. et al. "WE‐G‐141‐01: The Imaging and Radiation Oncology Core (IROC) Group: A Proposed New Clinical Trial Quality Assurance Organization." (1 2013).
  • Followill, D.; Knopp, M.; Galvin, J.; FitzGerald, T. et al. "The Imaging and Radiation Oncology Core (IROC) Group: A Proposed New Clinical Trial Quality Assurance Organization." (6 2013).
  • Followill, D.; Knopp, M.; Galvin, J.; FitzGerald, T. et al. "WE-G-141-01: The Imaging and Radiation Oncology Core (IROC) Group: A Proposed New Clinical Trial Quality Assurance Organization.." (6 2013).
  • Followill, D.; Knopp, M.; Galvin, J.; FitzGerald, T. et al. "The Imaging and Radiation Oncology Core (IROC) Group: A Proposed New Clinical Trial Quality Assurance Organization." (6 2013).

2012

  • Sammet, S.; Sammet, C.; Bourekas, E.; Schmalbrock, P. et al. "7-T Time of Flight MR Angiography." (5 2012).
  • Sammet, S.; Sammet, C.; Bourekas, E.; Schmalbrock, P. et al. "7-T Time of Flight MR Angiography." in Annual Meeting of the American-Roentgen-Ray-Society. (5 2012).

2011

  • Mayr, N.A.; Huang, Z.; Lo, S.S.; Jia, G. et al. "Therapy Outcome Prediction of Cervical Cancer with the Regression Rate of Physiologic High-risk Tumor Subvolume Assessed by DCE MRI." (1 2011).
  • Martin,L,K; Jia,G; Grecula,J; HARPER,E; Kefauver,C; Wei,L; Knopp,M; Delgado,I,JEspinoza; Grever,M; Bekaii-Saab,T "A Phase I Study of Triapine and Radiation in Patients With Locally Advanced Pancreas Cancer." in European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care. (9 2011).
  • Mayr,N,A; Huang,Z; Lo,S,S; Jia,G; Grecula,J,C; Zhang,J; Fan,J,M; Knopp,M,V; Yuh,W,TC "Therapy Outcome Prediction of Cervical Cancer with the Regression Rate of Physiologic High-risk Tumor Subvolume Assessed by DCE MRI." (1 2011).
  • Martin, L.K.; Jia, G.; Grecula, J.; Harper, E. et al. "A Phase I Study of Triapine and Radiation in Patients With Locally Advanced Pancreas Cancer." (9 2011).
  • Viswanathan,S; Wesolowski,R; Layman,R,M; Alejandra,G; Miller,B; Chalmers,J,J; Bejastani,S; Zhao,W; Pierluigu,G; Cotrill,J; Phelps,M,A; Schaaf,L,J; Geyer,S,M; Hall,N; Knopp,M,V; Shapiro,C,L; Villalona-Calero,M,A; Chen,A; Grever,M,R; Ramaswamy,B "A phase I dose-escalation study of ABT-888 (veliparib) in combination with carboplatin in HER2-negative metastatic breast cancer (MBC).." (5 2011).
  • Martin,L,K; Jia,G; Yang,X; Grecula,J,C; Harper,E,J; Kefauver,C; Wei,L; Shah,Z,K; Bloomston,M; Melvin,W,S; Muscarella,P; Ellison,E,C; Knopp,M,V; Delgado,I,Espinoza; Grever,M,R; Bekaii-Saab,T,S "A dose-escalating and pharmacodynamic study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine) and radiation in patients with locally advanced pancreas cancer.." (5 2011).
  • Martin, L.K.; Jia, G.; Grecula, J.; Harper, E. et al. "A Phase I Study of Triapine and Radiation in Patients With Locally Advanced Pancreas Cancer." in European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care. (9 2011).
  • Martin, L.K.; Jia, G.; Yang, X.; Grecula, J.C. et al. "A dose-escalating and pharmacodynamic study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine) and radiation in patients with locally advanced pancreas cancer.." (5 2011).
  • Ramaswamy, B.; Viswanathan, S.; Wesolowski, R.; Layman, R. et al. "A Phase 1 Dose-escalation Study of ABT-888 (veliparib) in Combination with Carboplatin in HER2 negative Metastatic Breast Cancer (MBC)." (6 2011).
  • Martin, L.K.; Jia, G.; Yang, X.; Grecula, J.C. et al. "A dose-escalating and pharmacodynamic study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine) and radiation in patients with locally advanced pancreas cancer.." (5 2011).
  • Mayr, N.A.; Huang, Z.; Lo, S.S.; Jia, G. et al. "Therapy Outcome Prediction of Cervical Cancer with the Regression Rate of Physiologic High-risk Tumor Subvolume Assessed by DCE MRI." (1 2011).

2010

  • Sammet, S.; Schmalbrock, P.; Bourekas, E.; Heverhagen, J. et al. "Time of Flight Magnetic Resonance Angiography of Micro Aneurysms at 7T." in 110th Annual Meeting of the American-Roentgen-Ray-Society. (5 2010).
  • Sammet,S; Griffin,R; Liang,J; Yang,X; Zhang,J; Hall,N; Shah MH; Knopp,M "3T Dynamic Contrast Enhanced MRI and PET/CT of Metastatic Medullary Thyroid Carcinoma." in 110th Annual Meeting of the American-Roentgen-Ray-Society. (5 2010).
  • Martin-Vaquero, P.; Da Costa, R.C.; Echandi, R.L.; Tosti, C.L. et al. "MAGNETIC RESONANCE IMAGING OF THE CANINE BRAIN AT 3.0T AND 7.0T." (5 2010).
  • Sammet, S.; Aguila, F.; Koch, R.; Knopp, M. "Residual Magnetism in MRI Suites After Quench and Controlled Rampdown of Superconducting Ultra-high Field Magnets." in 110th Annual Meeting of the American-Roentgen-Ray-Society. (5 2010).
  • Mayr, N.A.; Wang, J.Z.; Huang, Z.; Lo, S.S. et al. "Quantifying Absolute Functional Risk Volume with Functional Tumor Imaging for Treatment Outcome Prediction in Cervical Cancer." in 52nd Annual Meeting of the American-Society-For-Radiation-Oncology. (1 2010).
  • Mayr,N,A; Wang,J,Z; Huang,Z; Lo,S,S; Fan,J,M; Grecula,J,C; Sammet,S; Tosti,C,L; Knopp,M,V; Yuh,W,TC "Quantifying Absolute Functional Risk Volume with Functional Tumor Imaging for Treatment Outcome Prediction in Cervical Cancer." in 52nd Annual Meeting of the American-Society-for-Therapeutic-Radiation-Oncology (ASTRO). (1 2010).
  • Griffin, R.; Liang, J.; Rink, T.; Brandeberry, A. et al. "A quantitative study of perfusion using a gadolinium contrast agent for characterization of multiple sclerosis lesions." in 15th Annual Meeting of the Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis. (8 2010).
  • Sammet,S; Wei,W; Reiss,B; Liang,J; Jia,G; Aguila,F; Choi,S; Knopp,M "Comparison of a 32-Channel Coil and a Six-Channel Coil for MRI of the Prostate at 3T." in 110th Annual Meeting of the American-Roentgen-Ray-Society. (5 2010).
  • Sammet, S.; Griffin, R.; Liang, J.; Yang, X. et al. "3T Dynamic Contrast Enhanced MRI and PET/CT of Metastatic Medullary Thyroid Carcinoma." in 110th Annual Meeting of the American-Roentgen-Ray-Society. (5 2010).
  • Sammet, S.; Wei, W.; Reiss, B.; Liang, J. et al. "Comparison of a 32-Channel Coil and a Six-Channel Coil for MRI of the Prostate at 3T." in 110th Annual Meeting of the American-Roentgen-Ray-Society. (5 2010).
  • Sammet, S.; Griffin, R.; Liang, J.; Yang, X. et al. "3T Dynamic Contrast Enhanced MRI and PET/CT of Metastatic Medullary Thyroid Carcinoma." (5 2010).
  • Griffin, R.; Liang, J.; Rink, T.; Brandeberry, A. et al. "A quantitative study of perfusion using a gadolinium contrast agent for characterization of multiple sclerosis lesions." (8 2010).
  • Sammet, S.; Wei, W.; Reiss, B.; Liang, J. et al. "Comparison of a 32-Channel Coil and a Six-Channel Coil for MRI of the Prostate at 3T." (5 2010).
  • Sammet, S.; Aguila, F.; Koch, R.; Knopp, M. "Residual Magnetism in MRI Suites After Quench and Controlled Rampdown of Superconducting Ultra-high Field Magnets." (5 2010).
  • Mayr, N.A.; Wang, J.Z.; Huang, Z.; Lo, S.S. et al. "Quantifying Absolute Functional Risk Volume with Functional Tumor Imaging for Treatment Outcome Prediction in Cervical Cancer." (1 2010).
  • Sammet, S.; Clark, D.; Bhinder, A.; Tahiri, S. et al. "3T Dynamic Contrast MRI in a Phase II Trial of a Multitargeted Receptor Tyrosine Kinase Inhibitor in Relapsed and Refractory Gastroesophageal Cancers." (5 2010).
  • Sammet, S.; Schmalbrock, P.; Bourekas, E.; Heverhagen, J. et al. "Time of Flight Magnetic Resonance Angiography of Micro Aneurysms at 7T." (5 2010).
  • Sammet, S.; Clark, D.; Bhinder, A.; Tahiri, S. et al. "3T Dynamic Contrast MRI in a Phase II Trial of a Multitargeted Receptor Tyrosine Kinase Inhibitor in Relapsed and Refractory Gastroesophageal Cancers." in 110th Annual Meeting of the American-Roentgen-Ray-Society. (5 2010).
  • Martin-Vaquero, P.; Da Costa, R.C.; Echandi, R.L.; Tosti, C.L. et al. "MAGNETIC RESONANCE IMAGING OF THE CANINE BRAIN AT 3.0T AND 7.0T." (1 2010).

2009

  • Sammet, S.; Irfanoglu, O.; Koch, R.; Wassenaar, P. et al. "Postoperative Fiber Assessment Using Diffusion Tensor Imaging in a Brain Tumor Patient at 7T (CME Credit Available)." in 109th Annual Meeting of the American-Roentgen-Ray-Society. (5 2009).
  • Sammet, S.; Wassenaar, P.; Zalewski, S.; Stoez, M. et al. "Imaging of Meniscal Tear and Cartilage Damage at 1.5T, 3T, and 7T." in 109th Annual Meeting of the American-Roentgen-Ray-Society. (5 2009).
  • Burdette, D.; Albani, D.; Chesi, E.; Clinthorne, N.H. et al. "A Study on PET Image Quality Using Both Strong Magnetic Fields and a ML-EM Positron Range Correction Algorithm." (1 2009).
  • Christoforidis, G.; Rink, C.; Koch, R.; Kontzialis, M. et al. "Endovascular canine transient middle cerebral artery occlusion model with leptomeningeal collateral assessment." in 24th International Symposium on Cerebral Blood Flow and Metabolism/9th International Conference on Quantification of Brain Function with PET. (10 2009).
  • Burdette, D.; Albani, D.; Chesi, E.; Clinthorne, N. et al. "PET Artifacts from off-Plane Sources in High Magnetic Fields." in IEEE Nuclear Science Symposium/Medical Imaging Conference. (1 2009).
  • Christofordis, G.A.; Rink, C.; Koch, R.M.; Kontzialls, M. et al. "Endovascular Canine Transient Middle Cerebral Artery Occlusion Model." in American-Association-International-Stroke Conference 2009. (4 2009).
  • Sammet, S.; Koch, R.; Liang, J.; Jia, G. et al. "T1 and T2 Relaxation Times in Multiple Sclerosis Patients Before and After GadodiamideContrast Injection at 3T (CME Credit Available)." in 109th Annual Meeting of the American-Roentgen-Ray-Society. (5 2009).
  • Sammet, S.; Takayama, Y.; Jia, G.; Wang, W. et al. "3T MRI of Prostate Cancer without an Endorectal Coil: A Radiological-Pathological Correlation (CME Credit Available)." in 109th Annual Meeting of the American-Roentgen-Ray-Society. (5 2009).
  • Sammet, S.; Liang, J.; Koch, R.; Yang, X. et al. "Dynamic Contrast-Enhanced MR Imaging of Medullary Thyroid Carcinoma at 3T (CME Credit Available)." in 109th Annual Meeting of the American-Roentgen-Ray-Society. (5 2009).
  • Burdette, D.; Albani, D.; Chesi, E.; Clinthorne, N. et al. "PET Artifacts from off-Plane Sources in High Magnetic Fields." (1 2009).
  • Sammet,S; Koch,R; Liang,J; Jia,G; Knopp,M "T1 and T2 Relaxation Times in Multiple Sclerosis Patients Before and After GadodiamideContrast Injection at 3T (CME Credit Available)." in 109th Annual Meeting of the American-Roentgen-Ray-Society. (5 2009).
  • Lam, E.; Ringel, M.; Kloos, R.; Collamore, M. et al. "A phase II study of sorafenib in patients with metastatic medullary thyroid carcinoma." (5 2009).
  • Sammet, S.; Takayama, Y.; Jia, G.; Wang, W. et al. "3T MRI of Prostate Cancer without an Endorectal Coil: A Radiological-Pathological Correlation (CME Credit Available)." (5 2009).
  • Christoforidis,G; Rink,C; Koch,R; Kontzialis,M; Abduljalil,A; Mohammad,Y; Bergdall,V; Roy,S; Khanna,S; Slivka,A; Knopp,M; Sen,C "Endovascular canine transient middle cerebral artery occlusion model with leptomeningeal collateral assessment." in 24th International Symposium on Cerebral Blood Flow and Metabolism/9th International Conference on Quantification of Brain Function with PET. (10 2009).
  • Sammet, S.; Koch, R.; Liang, J.; Jia, G. et al. "T1 and T2 Relaxation Times in Multiple Sclerosis Patients Before and After GadodiamideContrast Injection at 3T (CME Credit Available)." (5 2009).
  • Christofordis, G.A.; Rink, C.; Koch, R.M.; Kontzialls, M. et al. "Endovascular Canine Transient Middle Cerebral Artery Occlusion Model." (4 2009).
  • Sammet,S; Takayama,Y; Jia,G; Wang,W; Shah,Z; Dangle,P; Jimenez,R; Patel,V; Knopp,M "3T MRI of Prostate Cancer without an Endorectal Coil: A Radiological-Pathological Correlation (CME Credit Available)." in 109th Annual Meeting of the American-Roentgen-Ray-Society. (5 2009).
  • Sammet, S.; Wassenaar, P.; Zalewski, S.; Stoez, M. et al. "Imaging of Meniscal Tear and Cartilage Damage at 1.5T, 3T, and 7T." (5 2009).
  • Sammet,S; Liang,J; Koch,R; Yang,X; Jia,G; Shah MH; Knopp,M "Dynamic Contrast-Enhanced MR Imaging of Medullary Thyroid Carcinoma at 3T (CME Credit Available)." in 109th Annual Meeting of the American-Roentgen-Ray-Society. (5 2009).
  • Sammet, S.; Irfanoglu, O.; Koch, R.; Wassenaar, P. et al. "Postoperative Fiber Assessment Using Diffusion Tensor Imaging in a Brain Tumor Patient at 7T (CME Credit Available)." (5 2009).
  • Sammet, S.; Liang, J.; Koch, R.; Yang, X. et al. "Dynamic Contrast-Enhanced MR Imaging of Medullary Thyroid Carcinoma at 3T (CME Credit Available)." (5 2009).
  • Lam, E.; Ringel, M.; Kloos, R.; Collamore, M. et al. "A phase II study of sorafenib in patients with metastatic medullary thyroid carcinoma." (5 2009).
  • Yuh, W.C.; Wang, J.Z.; Huang, Z.; Li, K. et al. "MRI-guided Brachytherapy for Cervical Cancer - Is Dynamic Contrast Enhanced MRI Useful?." in 51st Annual Meeting of the American-Society-for-Radiation-Oncology. (1 2009).
  • Burdette, D.; Albani, D.; Chesi, E.; Clinthorne, N.H. et al. "A study on PET image quality using both strong magnetic fields and a ML-EM positron range correction algorithm." (12 2009).
  • Christoforidis, G.; Rink, C.; Koch, R.; Kontzialis, M. et al. "Endovascular canine transient middle cerebral artery occlusion model with leptomeningeal collateral assessment." (10 2009).
  • Sammet, S.; Chaudhry, Z.; Coffey, R.; Crockett, A. et al. "MR Safety and Compatibility of Silver-Based Wound Dressings at 7T." (5 2009).
  • Sammet, S.; Chaudhry, Z.; Coffey, R.; Crockett, A. et al. "MR Safety and Compatibility of Silver-Based Wound Dressings at 7T." in 109th Annual Meeting of the American-Roentgen-Ray-Society. (5 2009).
  • Burdette, D.; Albani, D.; Chesi, E.; Clinthorne, N.H. et al. "A Study on PET Image Quality Using Both Strong Magnetic Fields and a ML-EM Positron Range Correction Algorithm." in IEEE Nuclear Science Symposium Conference 2009. (1 2009).
  • Sammet, S.; Schmalbrock, P.; Shah, J.; Boster, A. et al. "Multiple Sclerosis Lesion Characterization with MRI at 7T (CME Credit Available)." (5 2009).
  • Yuh, W.C.; Wang, J.Z.; Huang, Z.; Li, K. et al. "MRI-guided Brachytherapy for Cervical Cancer - Is Dynamic Contrast Enhanced MRI Useful?." (1 2009).
  • Sammet, S.; Schmalbrock, P.; Shah, J.; Boster, A. et al. "Multiple Sclerosis Lesion Characterization with MRI at 7T (CME Credit Available)." in 109th Annual Meeting of the American-Roentgen-Ray-Society. (5 2009).

2008

  • Dangle, P.P.; Samavedi, S.; Knopp, M.; Shah, Z. et al. "A radio-pathological correlation for prostate cancer detection - A study using DCE-MRI at 3T without an endorectal coil." (4 2008).
  • Hu, Y.; Jia, G.; Martin, D.D.; Takavama, Y. et al. "Magnetic resonance imaging guided tumor dose boost in prostate brachytherapy." in 50th Annual Meeting of the American-Society-for-Therapeutic-Radiology-and Oncology. (1 2008).
  • Mayr, N.A.; Wang, J.Z.; Zhang, D.; Grecula, J.C. et al. "Temporal changes in tumor perfusion pattern during the radiation therapy course and their clinical significance in cervical cancer." in 50th Annual Meeting of the American-Society-for-Therapeutic-Radiology-and Oncology. (1 2008).
  • Schmalbrock, P.; Racke, M.; Rammohan, K.; Boster, A. et al. "Multiple sclerosis lesion characterization with 7 Tesla magnetic resonance imaging." in 13th Annual Meeting of the Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/24th Congress of the European-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/5th Congress of the Latin-Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis. (9 2008).
  • Dangle, P.P.; Samavedi, S.; Knopp, M.; Shah, Z. et al. "A radio-pathological correlation for prostate cancer detection - A study using DCE-MRI at 3T without an endorectal coil." in 103rd Annual Meeting of the American-Urological-Association. (4 2008).
  • Fitzgerald, T.J.; White, K.; Saltz, J.; Sharma, A. et al. "Development of a Queriable Database for Oncology Outcome Analysis." in CURED II Meeting. (1 2008).
  • Hu, Y.; Jia, G.; Martin, D.D.; Takavama, Y. et al. "Magnetic resonance imaging guided tumor dose boost in prostate brachytherapy." (1 2008).
  • Hu,Y; Jia,G; Martin,D,D; Takavama,Y; Shah,Z,K; Kim,E,Y; Mayr,N,A; Knopp,M,V; Wang,J,Z "Magnetic resonance imaging guided tumor dose boost in prostate brachytherapy." in 50th Annual Meeting of the American-Society-for-Therapeutic-Radiology-and-Oncology. (1 2008).
  • Dangle,Pankaj,P; Samavedi,Srinivas; Knopp,Michael; Shah,Zarine; Jia,Guang; Takayama,Yukihisa; Jimenez,Rafael; Patel,Vipul,R "A radio-pathological correlation for prostate cancer detection - A study using DCE-MRI at 3T without an endorectal coil." in 103rd Annual Meeting of the American-Urological-Association. (4 2008).
  • Fitzgerald, T.J.; White, K.; Saltz, J.; Sharma, A. et al. "Development of a Queriable Database for Oncology Outcome Analysis." (1 2008).
  • Schmalbrock, P.; Racke, M.; Rammohan, K.; Boster, A. et al. "T2 in normal-appearing gray matter in multiple sclerosis measured at 3 Tesla and 7 Tesla magnetic resonance imaging." in 13th Annual Meeting of the Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/24th Congress of the European-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/5th Congress of the Latin-Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis. (9 2008).
  • Mayr,N,A; Wang,J,Z; Zhang,D; Grecula,J,C; Lo,S,S; Zhang,H; Li,K; Fowler,J; Knopp,M,V; Yuh,W,TC "Temporal changes in tumor perfusion pattern during the radiation therapy course and their clinical significance in cervical cancer." in 50th Annual Meeting of the American-Society-for-Therapeutic-Radiology-and-Oncology (ASTRO). (1 2008).
  • Mayr, N.A.; Wang, J.Z.; Zhang, D.; Grecula, J.C. et al. "Temporal changes in tumor perfusion pattern during the radiation therapy course and their clinical significance in cervical cancer." (1 2008).
  • Schmalbrock, P.; Racke, M.; Rammohan, K.; Boster, A. et al. "Multiple sclerosis lesion characterization with 7 Tesla magnetic resonance imaging." (9 2008).
  • Schmalbrock, P.; Racke, M.; Rammohan, K.; Boster, A. et al. "T2 in normal-appearing gray matter in multiple sclerosis measured at 3 Tesla and 7 Tesla magnetic resonance imaging." (9 2008).

2007

  • Sammet, S.; Jia, G.; Koch, R.M.; Schmalbrock, P. et al. "In-vivo Magnetic Resonance Imaging of the Prostate at 7 Tesla." (5 2007).
  • Burdette, D.; Albani, D.; Chesi, E.; Clinthorne, N. et al. "A study of the effects of strong magnetic fields on the image resolution of PET scanners." in IEEE Nuclear Science Symposium/Medical Imaging Conference. (1 2007).
  • Sammet,S; Jia,G; Koch,R,M; Schmalbrock,P; Knopp,M "In-vivo Magnetic Resonance Imaging of the Prostate at 7 Tesla." (5 2007).
  • Yuh, W.T.C.; Christoforidis, G.A.; Sammet, S.; Koch, R.M. et al. "Ultra-high field clinical MRI of normal human brain and glioma." (1 2007).
  • Sammet, S.; Koch, R.M.; Sparks, J.; Bolte, J.H. et al. "CT Imaging of Liver Injuries to Create a Model for Blunt Hepatic Trauma." (5 2007).
  • Sammet, S.; Schmalbrock, P.; Chakeres, D.W.; Wassenaar, P. et al. "High-Resolution Magnetic Resonance Imaging of the Substantia Nigra at 7.0 T." (5 2007).
  • Sammet, S.; Jia, G.; Koch, R.M.; Schmalbrock, P. et al. "In-vivo Magnetic Resonance Imaging of the Prostate at 7 Tesla." (5 2007).
  • Sammet, S.; Koch, R.M.; Sparks, J.; Bolte, J.H. et al. "CT Imaging of Liver Injuries to Create a Model for Blunt Hepatic Trauma." (5 2007).
  • Burdette, D.; Albani, D.; Chesi, E.; Clinthorne, N. et al. "A study of the effects of strong magnetic fields on the image resolution of PET scanners." (12 2007).
  • Yuh, W.T.C.; Christoforidis, G.A.; Sammet, S.; Koch, R.M. et al. "Ultra-high field clinical MRI of normal human brain and glioma." in 49th Annual Meeting of the American-Society-for-Therapeutic-Radiology-and-Oncology. (1 2007).
  • Koch,R,M; Christoforidis,G,A; Yuh,W,TC; Yang,M; Schmalbrock,P; Sannnet,S; Mayr,N,A; Grecula,J,C; Knopp,M,V "Comparison of 8T and 1.5T MRI for detecting brain metastases." in 49th Annual Meeting of the American-Society-for-Therapeutic-Radiology-and-Oncology (ASTRO). (1 2007).
  • Koch, R.M.; Christoforidis, G.A.; Yuh, W.T.C.; Yang, M. et al. "Comparison of 8T and 1.5T MRI for detecting brain metastases." (1 2007).
  • Sammet, S.; Schmalbrock, P.; Chakeres, D.W.; Wassenaar, P. et al. "High-Resolution Magnetic Resonance Imaging of the Substantia Nigra at 7.0 T." (5 2007).
  • Burdette, D.; Albani, D.; Chesi, E.; Clinthorne, N. et al. "A study of the effects of strong magnetic fields on the image resolution of PET scanners." (1 2007).
  • Koch, R.M.; Christoforidis, G.A.; Yuh, W.T.C.; Yang, M. et al. "Comparison of 8T and 1.5T MRI for detecting brain metastases." in 49th Annual Meeting of the American-Society-for-Therapeutic-Radiology-and-Oncology. (1 2007).

2006

  • Kloos,R; Ringel,M; Knopp,M; Heverhagen,J; Rittenberry,J; WELDY,L; Arbogast,D; Collamore,M; King,M; Young,D; Shah MH "Significant clinical and biologic activity of RAF/VEGF-R kinase inhibitor BAY 43-9006 in patients with metastatic papillary thyroid carcinoma (PTC): Updated results of a phase II study.." in 42nd Annual Meeting of the American-Society-of-Clinical-Oncology. (6 2006).
  • Kloos, R.; Ringel, M.; Knopp, M.; Heverhagen, J. et al. "Significant clinical and biologic activity of RAF/VEGF-R kinase inhibitor BAY 43-9006 in patients with metastatic papillary thyroid carcinoma (PTC): Updated results of a phase II study.." in 42nd Annual Meeting of the American-Society-of-Clinical-Oncology. (6 2006).
  • Wood,J; Heverhagen,J; Yang,X; Jia,G; Koch,R,M; Jacko,R; Sammet,S; Enriquez,C; Nord,A; Allegrini,P; Holland,J; Jensen,P,D; Pellas,Gandon,T; Knopp,M; Cole,P; Coates,Thomas,D "Imaging core lab comparison of five clinical liver iron MRI methods and biopsy for hepatic iron concentration (HIC) in sickle cell disease (SCD) patients.." in 48th Annual Meeting of the American-Society-of-Hematology. (11 2006).
  • Kloos, R.; Ringel, M.; Knopp, M.; Heverhagen, J. et al. "Significant clinical and biologic activity of RAF/VEGF-R kinase inhibitor BAY 43-9006 in patients with metastatic papillary thyroid carcinoma (PTC): Updated results of a phase II study.." (6 2006).
  • Wood, J.; Heverhagen, J.; Yang, X.; Jia, G. et al. "Imaging core lab comparison of five clinical liver iron MRI methods and biopsy for hepatic iron concentration (HIC) in sickle cell disease (SCD) patients.." in 48th Annual Meeting of the American-Society-of-Hematology. (11 2006).
  • Wood, J.; Heverhagen, J.; Yang, X.; Jia, G. et al. "Imaging core lab comparison of five clinical liver iron MRI methods and biopsy for hepatic iron concentration (HIC) in sickle cell disease (SCD) patients.." (11 2006).

2005

  • Kale, M.C.; Heverhagen, J.T.; Clymer, B.D.; Knopp, M.V. "Dynamic contrast enhanced magnetic resonance imaging parameter based computer assisted diagnostic tool using three random variable co-occurrence approach." (12 2005).
  • Kale, M.C.; Clymer, B.D.; Heverhagen, J.T.; Knopp, M.V. "Dynamic contrast enhanced magnetic resonance imaging parameter based computer assisted diagnostic tool using three random variable co-occurrence approach." in 7th IASTED International Conference on Signal and Image Processing. (1 2005).
  • Kale, M.C.; Clymer, B.D.; Heverhagen, J.T.; Knopp, M.V. "Dynamic contrast enhanced magnetic resonance imaging parameter based computer assisted diagnostic tool using three random variable co-occurrence approach." (1 2005).

2004

  • Heverhagen, J.T.; von Tengg-Kobligk, H.; Schmalbrock, R.; Davidorf, F.H. et al. "Ex vivo high resolution MRI of intraocular lesions." (1 2004).
  • Heverhagen, J.T.; von Tengg-Kobligk, H.; Schmalbrock, R.; Davidorf, F.H. et al. "Ex vivo high resolution MRI of intraocular lesions." in 104th Annual Meeting of the American-Roentgen-Ray-Society. (1 2004).

2000

  • Henze, M.; Brix, G.; Knopp, M.; Lucht, R. et al. "Functional breast imaging: Comparison of F-18-fluordeoxyglucose (FDG) PET and pharmacokinetic MR mapping (DMRI).." (5 2000).
  • Henze, M.; Brix, G.; Knopp, M.; Lucht, R. et al. "Functional breast imaging: Comparison of F-18-fluordeoxyglucose (FDG) PET and pharmacokinetic MR mapping (DMRI).." (5 2000).

1998

  • Schlemmer, H.P.; Dietz, A.; Becker, M.; Wollensack, P. et al. "Monitoring of 5-FU pharmacokinetics in cervical lymph node metastases from head and neck carcinomas by means of in vivo 19F MR spectroscopy." (1 1998).
  • Schlemmer, H.P.; Dietz, A.; Becker, M.; Wollensack, P. et al. "Monitoring of 5-FU pharmacokinetics in cervical lymph node metastases from head and neck carcinomas by means of in vivo 19F MR spectroscopy." (1 1998).

1997

  • Strauss, L.G.; Schad, L.; DimitrakopoulouStrauss, A.; Knopp, M. et al. "PET with F-18-FDG and O-15-water and Gd-DTPA MRI in patients with brain tumors receiving radiotherapy.." (5 1997).
  • Strauss, L.G.; Schad, L.; DimitrakopoulouStrauss, A.; Knopp, M. et al. "PET with F-18-FDG and O-15-water and Gd-DTPA MRI in patients with brain tumors receiving radiotherapy.." (5 1997).

1996

  • Knopp, M. "Evaluation of response by functional magnetic resonance mammography." (10 1996).

1992

  • STRAUSS, L.G.; DIMITRAKOPOULOU, A.; HABERKORN, U.; CLORIUS, J.H. et al. "PET FOR TUMOR-DIAGNOSIS AND THERAPY MANAGEMENT IN ONCOLOGIC PATIENTS." (8 1992).
  • STRAUSS, L.G.; DIMITRAKOPOULOU, A.; HABERKORN, U.; CLORIUS, J.H. et al. "PET FOR TUMOR-DIAGNOSIS AND THERAPY MANAGEMENT IN ONCOLOGIC PATIENTS." (8 1992).

Unknown

  • "A Qualitative SPECT/CT Assessment of Intratumoral 99mTc-Macro-Aggregated Albumin in Predicting Response to Liver Radioembolization with 90Y Microspheres." in Society of Nuclear Medicine & Molecular Imaging (SNMMI) Annual Meeting 2015.
  • "Dynamic-Contrast Enhanced MR and Volume Regression rate as a preoperative predictive assay in patients with Non Small Cell Lung Cancer." in American Society for Radiation Oncology (ASTRO).
  • Zhang, J.; Zhang, B.; Hu, Z.; Knopp, M.V. "Evaluation of Sparse-Ring Digital Photon Counting Time-of-Flight PET: How Many SiPM Detector Elements Do We Really Need?." in IEEE.
  • Ramaswamy, B.; Mrózek, E.; Lustberg, M.B.; Knopp, M.V. et al. "Phase II trial of neoadjuvant chemotherapy (NCT) with weekly nanoparticle albumin-bound paclitaxel (Nab-P), carboplatin (CBP), and bevacizumab (BEV) in women with clinical stages II-III breast cancer (BC): Pathologic response prediction by changes in angiogenic volume (AV) by dynamic contrast magnetic resonance imaging (DCE-MRI)."
  • Zhang, J.; Siva, A.; Bhatia, P.; Binzel, K.M. et al. "Adaptive Optimization of the Number of OSEM Subsets improves Image Quality and Lesion Detectability in Time-of-Flight FDG PET." in RSNA.
  • Zhang, J.; Siva, A.; Bhatia, P.; Binzel, K.M. et al. "Best in Class Time of Flight PET Performance What is the Clinical Benefit?." in RSNA.
  • Binzel KM, Zhang J, Hall N, Ramaswamy B, Knopp MV "Decreasing radiation dose and acquisition time in F-18-FLT PET/CT." in OSUWMC Research Day 2012.

Patents

  • Bjoernerud A, Briley-Saebo K, Knopp MV, McGill S, Schoenberg SO. "Method of Magnetic Resonance Imaging." Patent number: WO0072037
  • Knopp MV, Giesel F, von Tengg-Kobligk H, Radeleff J. "[Imaging of the Colon Using Contrast Agents]." Patent number: ITMI20000193
  • Schoenberg SO, Bock M, Knopp MV, Laub G. "Method for Separating Arteries and Veins in 3D MR Angiographic Images Using Correlation Analysis." Patent number: US6,377,835
  • Knopp MV, Giesel F, von Tengg-Kobligk H, Radeleff J. "Use of Contrast Agents in the Manufacture of Diagnostic Agent for the Visualisation of the Intestinal Lumen." Patent number: PT1251875T